WO2005056543A2 - Process for use in the preparation of oxiranes from alkenes, and catalysts for use therein - Google Patents

Process for use in the preparation of oxiranes from alkenes, and catalysts for use therein Download PDF

Info

Publication number
WO2005056543A2
WO2005056543A2 PCT/GB2004/004936 GB2004004936W WO2005056543A2 WO 2005056543 A2 WO2005056543 A2 WO 2005056543A2 GB 2004004936 W GB2004004936 W GB 2004004936W WO 2005056543 A2 WO2005056543 A2 WO 2005056543A2
Authority
WO
WIPO (PCT)
Prior art keywords
optionally substituted
group
hydrogen
catalyst
formula
Prior art date
Application number
PCT/GB2004/004936
Other languages
French (fr)
Other versions
WO2005056543A3 (en
Inventor
Benjamin Roger Buckley
David Barros Aguirre
Philip Charles Bulman Page
Original Assignee
Avecia Pharmaceuticals Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Avecia Pharmaceuticals Limited filed Critical Avecia Pharmaceuticals Limited
Publication of WO2005056543A2 publication Critical patent/WO2005056543A2/en
Publication of WO2005056543A3 publication Critical patent/WO2005056543A3/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D301/00Preparation of oxiranes
    • C07D301/02Synthesis of the oxirane ring
    • C07D301/03Synthesis of the oxirane ring by oxidation of unsaturated compounds, or of mixtures of unsaturated and saturated compounds
    • C07D301/12Synthesis of the oxirane ring by oxidation of unsaturated compounds, or of mixtures of unsaturated and saturated compounds with hydrogen peroxide or inorganic peroxides or peracids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D301/00Preparation of oxiranes
    • C07D301/02Synthesis of the oxirane ring
    • C07D301/03Synthesis of the oxirane ring by oxidation of unsaturated compounds, or of mixtures of unsaturated and saturated compounds
    • C07D301/14Synthesis of the oxirane ring by oxidation of unsaturated compounds, or of mixtures of unsaturated and saturated compounds with organic peracids, or salts, anhydrides or esters thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D301/00Preparation of oxiranes
    • C07D301/36Use of additives, e.g. for stabilisation

Definitions

  • This invention relates to a process for the preparation of oxiranes from alkenes, preferably asymmetrically.
  • a process for the preparation of oxiranes wherein an optionally substituted alkene is reacted in the presence of a chiral catalyst, an oxidant and an organic solvent characterised in that the oxidant is at least partially soluble in the organic solvent and the oxidant displays low reactivity towards the alkene in the absence of the catalyst.
  • the optionally substituted alkene is preferably an alkene of formula (1):
  • R 1"4 each independently are hydrogen, an optionally substituted aromatic or saturated hydrocarbyl, an optionally substituted hetrocyclyl, an optionally substituted aromatic or saturated hydrocarbyloxy, an optionally substituted aromatic or saturated hydrocarbylamino, an optionally substituted aromatic or saturated hydrocarbyloxycarbonyl, an optionally substituted aromatic or saturated hydrocarbylaminocarbonyl, nitrile, halide or one or more of R 1 & R 2 , R 2 & R 3 , R 3 & R 4 , R 1 & R 4 optionally being linked in such a way as to form an optionally substituted ring(s).
  • R 1"4 each independently are hydrogen, an optionally substituted aromatic or saturated hydrocarbyl, an optionally substituted hetrocyclyl, or one or more of R 1 & R 2 , R 2 & R 3 , R 3 & R 4 , R 1 & R 4 optionally being linked in such a way as to form an optionally substituted ring(s).
  • at least one of R ⁇ R 2 , R 3 or R 4 is selected to be different from the remaining groups, or one or more of R 1 & R 2 , R 2 & R 3 , R 3 & R 4 , R 1 & R 4 are linked in such a way as to form an optionally substituted unsymmetrical ring(s).
  • R ⁇ R 2 , R 3 or R 4 is hydrogen, with the remaining R 1"4 groups being the same or different.
  • at least one of R ⁇ R 2 , R 3 or R 4 is an aryl group, with the remaining R 1"4 being the same or different.
  • the compound of formula (1 ) is a Z (or cis) isomer.
  • Aromatic or saturated hydrocarbyl groups which may be represented by R 1"4 independently include alkyl and aryl groups and any combination thereof, such as aralkyl and alkaryl, for example benzyl groups.
  • Alkyl groups which may be represented by R 1"4 include linear and branched alkyl groups comprising up to 20 carbon atoms, particularly from 1 to 7 carbon atoms and preferably from 1 to 5 carbon atoms. When the alkyl groups are branched, the groups often comprising up to 10 branch chain carbon atoms, preferably up to 4 branch chain atoms. In certain embodiments, the alkyl group may be cyclic, commonly comprising from 3 to 10 carbon atoms in the largest ring and optionally featuring one or more bridging rings.
  • alkyl groups which may be represented by R 1"4 include methyl, ethyl, propyl, 2-propyl, butyl, 2-butyl, t-butyl and cyclohexyl groups.
  • Aryl groups which may be represented by R 1"4 may contain 1 ring or 2 or more fused rings which may include cycloalkyl, aryl or heterocyclic rings.
  • Examples of aryl groups which may be represented by R 1"4 include phenyl, tolyl, fluorophenyl, chlorophenyl, bromophenyl, trifluoromethylphenyl, anisyl, naphthyl and ferrocenyl groups.
  • Aromatic or saturated heterocyclic groups which may be represented by R 1"4 independently include aromatic, saturated ring systems and may constitute 1 ring or 2 or more fused rings which may include cycloalkyl, aryl or heterocyclic rings.
  • the heterocyclic group will contain at least one heterocyclic ring, the largest of which will commonly comprise from 3 to 7 ring atoms in which at least one atom is carbon and at least one atom is any of N, O, S or P.
  • Examples of heterocyclic groups which may be represented by R "4 include pyridyl, pyrimidyl, pyrrolyl, thiophenyl, furanyl, indolyl, quinolyl, isoquinolyl, imidazoyl and triazoyl groups.
  • Optionally substituted aromatic or saturated hydrocarbyloxy groups which may be represented by R 1"4 independently include alkyoxy and aryloxy groups and any combination thereof, such as aralkyloxyl and alkaryloxyl, for example benzyloxy groups.
  • Optionally substituted aromatic or saturated hydrocarbylamino groups which may be represented by R 1"4 independently include mono and d-alkylamino and mono and di- arylamino groups and any combination thereof, such as aralkylamino and alkarylamino, for example benzylamino and benzylmethylamino groups.
  • Optionally substituted aromatic or saturated hydrocarbyloxycarbonyl groups which may be represented by R 1"4 independently include alkyoxycarbonyl and aryloxycarbonyl groups and any combination thereof, such as aralkyloxycarbonyl and alkaryloxycarbonyl, for example benzyloxycarbonyl groups.
  • Optionally substituted aromatic or saturated hydrocarbylaminocarbonyl groups which may be represented by R 1"4 independently include mono- and di-alkyaminocarbonyl and mono and di-arylaminocarbonyl groups and any combination thereof, such as aralkylaminocarbonyl and alkarylaminocarbonyl, for example benzylaminocarbonyl groups.
  • Halides which may be represented by R "4 independently include fluorine, chlorine, bromine and iodine.
  • R 1"4 is a substituted aromatic or saturated hydrocarbyl, a substituted heterocyclic group, a substituted aromatic or saturated hydrocarbyloxy, a substituted aromatic or saturated hydrocarbylamino, a substituted aromatic or saturated hydrocarbyloxycarbonyl, a substituted aromatic or saturated hydrocarbylaminocarbonyl
  • the substituent(s) should be such so as not to adversely affect the rate or stereoselectivety of the reaction.
  • Optional substituents include halogen, cyano, nitro, hydroxy, amino, thiol, acyl, hydrocarbyl, perhalogentated hydrocarbyl, heterocyclyl, hydrocarbyloxy, mono or di-hydrocarbylamino, hydrocarbylthio, esters, carbonates, amides, sulphonyl and sulphonamido groups wherein the hydrocarbyl groups are as defined for R 1 above.
  • One or more substituents may be present. Where the substituted aromatic or saturated hydrocarbyl group is fully substituted by halogen substituents, the group is referred to as a perhalogenated aromatic or saturated hydrocarbyl group.
  • Perhalogenated aromatic or saturated hydrocarbyl groups which may be represented by R 1"4 independently include perhalogenated alkyl and aryl groups, and any combination thereof, such as aralkyl and alkaryl groups.
  • Examples of perhalogenated alkyl groups which may be represented by R 1"4 include -CF 3 and -C 2 F 5 .
  • the ring atoms may in addition to carbon atoms may optionally comprise one or more heteroatoms, preferably selected from N, O, S or P.
  • R 1 & R 2 , R 2 & R 3 , R 3 & R 4 , R 1 & R 4 are linked in such a way that when taken together with the carbon atoms to which they are attached that an optionally substituted ring is formed, the rings atoms are carbon atoms.
  • R 1 & R 2 , R 2 & R 3 , R 3 & R 4 , R 1 & R 4 are linked in such a way that when taken together with the carbon atoms to which they are attached that an optionally substituted ring is formed, that the ring is a 5, 6 or 7 membered rings.
  • R 1 & R 2 , R 2 & R 3 , R 3 & R 4 , R 1 & R 4 are linked in such a way that when taken together with the carbon atoms to which they are attached that an optionally substituted ring is formed
  • the optional substituents include halogen, cyano, nitro, hydroxy, amino, thiol, acyl, hydrocarbyl, perhalogentated hydrocarbyl, heterocyclyl, hydrocarbyloxy, mono or di-hydrocarbylamino, hydrocarbylthio, esters, carbonates, amides, sulphonyl and sulphonamido groups wherein the hydrocarbyl groups are as defined for R 1 above.
  • One or more substituents may be present. Examples of such compounds of formula (1 ) include:
  • Oxidants which show appropriate levels of solubility in organic solvents and which show no appreciable levels of epoxidation of the alkene in the absence of the catalyst in the range 0°C to -78°C are preferred.
  • Preferred oxidants include oxidants of formula (2):
  • a + is a counterion capable of conferring organic solvent solubility.
  • Preferred counterions which are represented by A + include (PR 6 R 7 R 8 R 9 ) + wherein R 6"9 are optionally substituted aryl groups.
  • Optionally substituted aryl groups are as described above for R 1"4 .
  • More preferably the oxidants are compounds of formula (3):
  • R 10 is hydrogen, a polyfluorinated alkyl, a resin or a linker bound to a resin.
  • Polyfluorinated alkyl groups which may be represented by R 10 include partial and fully halogenated alkyl groups, preferably fully halogenated alkyl group. Examples of polyfluorinated alkyl groups include CF 3 .
  • R 0 is hydrogen.
  • the chiral catalyst is often a chiral iminium salt.
  • the chiral catalyst is preferably a chiral iminium salt of formula (4):
  • R 11 and R 12 are each independently an optionally substituted hydrocarbyl group or R 11 & R 12 are linked in such a way as to form an optionally substituted ring(s);
  • R 13 is hydrogen or an optionally substituted hydrocarbyl group;
  • R 14 is an optionally substituted hydrocarbyl group;
  • R 17 is hydrogen or an optionally substituted hydrocarbyl group;
  • R 15 and R 16 each independently are hydrogen or an optionally substituted hydrocarbyl group; and
  • X " is a counterion; * is a chiral centre; and * ' is a chiral centre when R 17 is not hydrogen.
  • R 11 & R 12 are linked in such a way as to form an optionally substituted ring(s);
  • R 13 is hydrogen;
  • R 14 is an optionally substituted hydrocarbyl group;
  • R 17 is hydrogen or an optionally substituted hydrocarbyl group;
  • R 15 and R 16 each independently are hydrogen or an optionally substituted hydrocarbyl group; and * is a chiral centre
  • Hydrocarbyl groups which may be represented by R 11"17 independently include alky and aryl groups and any combination thereof, such as aralkyl and alkaryl, for example benzyl groups.
  • Alkyl groups which may be represented by R 11"17 include linear and branched alkyl groups comprising up to 20 carbon atoms, particularly from 1 to 7 carbon atoms and preferably from 1 to 5 carbon atoms. When the alkyl groups are branched, the groups often comprising up to 10 branch chain carbon atoms, preferably up to 4 branch chain atoms. In certain embodiments, the alkyl group may be cyclic, commonly comprising from 3 to 10 carbon atoms in the largest ring and optionally featuring one or more bridging rings.
  • alkyl groups which may be represented by R 1 "17 include methyl, ethyl, propyl, 2-propyl, butyl, 2-butyl, t-butyl and cyclohexyl groups.
  • Aryl groups which may be represented by R 11"17 may contain 1 ring or 2 or more fused rings which may include cycloalkyl, aryl or heterocyclic rings.
  • Examples of aryl groups which may be represented by R 11"17 include phenyl, tolyl, fluorophenyl, chlorophenyl, bromophenyl, trifluoromethylphenyl, anisyl, naphthyl and ferrocenyl groups.
  • Aromatic or saturated heterocyclic groups which may be represented by R 11"17 independently include aromatic, saturated ring systems and may constitute 1 ring or 2 or more fused rings which may include cycloalkyl, aryl or heterocyclic rings.
  • the heterocyclic group will contain at least one heterocyclic ring, the largest of which will commonly comprise from 3 to 7 ring atoms in which at least one atom is carbon and at least one atom is any of N, O, S or P.
  • Examples of heterocyclic groups which may be represented by R 1"17 include pyridyl, pyrimidyl, pyrrolyl, thiophenyl, furanyl, indolyl, quinolyl, isoquinolyl, imidazoyl and triazoyl groups.
  • R 11"17 is a substituted aromatic or saturated hydrocarbyl or a substituted heterocyclic group
  • the substituent(s) should be such so as not to adversely affect the rate or stereoselectivety of the reaction.
  • Optional substituents include halogen, cyano, nitro, hydroxy, amino, thiol, acyl, hydrocarbyl, perhalogentated hydrocarbyl, heterocyclyl, hydrocarbyloxy, mono or di-hydrocarbylamino, hydrocarbylthio, esters, carbonates, amides, sulphonyl and sulphonamido groups wherein the hydrocarbyl groups are as defined for R 1 above.
  • One or more substituents may be present.
  • Perhalogenated aromatic or saturated hydrocarbyl groups which may be represented by R 11"17 independently include perhalogenated alkyl and aryl groups, and any combination thereof, such as aralkyl and alkaryl groups.
  • Examples of perhalogenated alkyl groups which may be represented by R 11"17 include -CF 3 and -C 2 F 5 .
  • Optional substituents include halogen, cyano, nitro, hydroxy, amino, thiol, acyl, hydrocarbyl, perhalogentated hydrocarbyl, heterocyclyl, hydrocarbyloxy, mono or di-hydrocarbylamino, hydrocarbylthio, esters, carbonates, amides, sulphonyl and sulphonamido groups wherein the hydrocarbyl groups are as defined for R 1 above.
  • One or more substituents may be present.
  • Catalysts of Formula (4) may optionally be attached to a resin. Preferably attachment to a resin via an optional linker may suitably achieved by substitution on one or more of R 11 , R 12 , R 14 or R 17 .
  • Counterions which may be represented by X " include anions which confer organic solubility, preferably delocalised anions, more preferably[BPh 4 ] ⁇
  • Examples of counterions which may be represented by X include [BF 4 ] ' , [CF 3 SO 3 ]-, [BPh 4 ]-, [PF 6 ] ' and [CIO 4 ]-.
  • Preferred catalysts are compounds of formula (4a), (4b), (4c) and (4d): (4a) (4b) (4c) (4d)
  • R 14 is an optionally substituted aryl group, preferably an optionally substituted phenyl group
  • R 5 is hydrogen or C 1-4 alkyl group, preferably hydrogen or a methyl group, most preferably a methyl group
  • R 16 is hydrogen or C 1-4 alkyl group, preferably hydrogen or a methyl group, most preferably a methyl group
  • R 18 and R 19 are each independently hydrogen or a C 1-4 alkyl group, preferably hydrogen or a methyl group, most preferably both are methyl groups
  • R 20 is preferably an electron donating group, more preferably dihydrocarbylamino; and is a counterion, preferably [BF 4 ] _ , [CF 3 SO 3 ]-, [BPh 4 ] " , [PF 6 ] _ and [CIO 4 ] ⁇
  • Organic solvents suitable for use in the process of present invention include polar and non-polar organic solvents, especially hydrocarbons, for example benzene, toluene and xylene, halogented hydrocarbons, for example choloroform and methylene chloride, ethers, for example tetrahydrofuran, t-butyl methyl ether and diglyme, alcohols, such as C 4 .
  • aliphatic alcohols especially pentanol and hexanol and isomers thereof, cyclohexanol, acetonitrile, and polar aprotic solvents, for example N-methyl pyrrolidone, dimethylformamide, N,N-dimethylacetamide or dimethyl sulphoxide, and mixtures thereof.
  • Preferred organic solvents are acetonitrile, methylene chloride and chloroform.
  • the choice of organic solvent or organic solvent mixtures is typically influenced by the solubility of the substrate, the catalyst and the oxidant. Unusually, for certain substrates, it has been found that the choice of solvent may influence the stereospecificity of the reaction.
  • the substrate is a trans tri-substituted alkene
  • chlorinated solvents leads to a predominance of one enatiomeric 5 product
  • acetonitrile leads to a predominance of the other enantiomeric product.
  • the process of the present invention may optionally be carried out in the presence of a base.0 Suitably the process is carried out at temperatures in the range of from minus 85 to plus 50°C, preferably from minus 78 to plus 35°C and more preferably from minus 40 to plus 25°C.
  • the initial concentration of the alkene, a compound of formula (1 ), is suitably in the range 0.1 to 100 %wt/v and, for convenient larger scale operation, can be for example up5 to 20%wt/v more especially 0.5 to 10% wt v.
  • the molar ratio of the substrate to catalyst is suitably no less than 10:1 and can be up to 1000:1 , preferably between 10:1 and 100:1 and more preferably between 20:1 and 1 :1.
  • the oxidant is preferably employed in a molar excess over the substrate, especially about a 2 fold excess. Reaction times are typically in the range of from 3 min to 24h, especially up to 24h and conveniently about0 4h. After the reaction is complete, the resulting mixture is worked up by standard procedures. Typically, addition of diethyl ether results in precipitation of the oxidant which is removed by filtration leaving the product in solution.
  • the amino diol (1.0 equiv.) was dissolved in methanol (10 ml/g) and methyl formate (1.1 equiv.) was added with sodium methoxide (10 mol%). The reaction was left to stir for 3.5h and the solvent removed under reduced pressure. The crude yellow oil was 5 dissolved with CSA (10 mol%) in acetone (50 ml/g) and 2,2-dimethoxypropane (10.0 equiv.). The reaction was left to stir for up to 4h and monitored by thin layer chromatography (TLC). Solvents were removed under reduced pressure and the residue re-dissolved in ethyl acetate, which was washed with sat. aq. sodium hydrogen carbonate. The organics were dried (MgSO 4 ) and solvents removed under reduced pressure.
  • the formate protected acetonide was dissolved in aq. hydrazine hydrate (85%) (20 ml/g) and the solution heated under reflux for 2.5 h. The solution was allowed to cool to room temperature and extracted with ethyl acetate (3 x 20 ml/g). The organic layers were washed with water (2 x 20 ml/g), dried (MgSO 4 ) and solvents removed under reduced pressure.
  • (4S,5S)-2,2-dimethyl-4-[4-nitro-phenyl]-1,3-dioxan-5-amine Prepared according to the general procedure from ⁇ /-[(4S,5S)-2,2-Dimethyl-4-[4-nitro- phenyl]-1 ,3-dioxan-5-yl]formamide (4.00 g, 14.9 mmol), except reaction heated under reflux for 1 h. Chromatography performed eluting with ethylacetate. Pale yellow plates. (2.80 g, 78%); mp 117-119°C; [ ⁇ ] D 20 +66.2° (c 1.13, CHCI 3 ); Found: C, 57.05; H, 6.51 ; N, 10.77.
  • (+)-[(4S,5S)-2,2-dimethyl-4-[4-(nitro)-phenyl]-1,3-dioxan-5-yl]-dihydroisoquinolinium tetraphenylborate:0 Prepared according to the general procedure from (+)-(4S,5S)-2,2-dimethyl-4-[4-(nitro)- phenyl]-1 ,3-dioxan-5-amine (0.19 g, 0.8 mmol). Recrystallized from DCM/hexane, yellow plates (0.36 g, 74%); m.p.
  • (+)-[(4S,5S)-2,2-dimethyl-4-[4-(methylsulfonyl)-phenyl]-1,3-dioxan-5-yl]-3,4-5 dihydroisoquinolinium tetraphenylborate Prepared according to the general procedure from (4S,5S)-2,2-dimethyl-4-[4- (methylsulfonyl)-phenyl]-1 ,3-dioxan-5-amine (0.75 g, 2.96 mmol). Recrystallized from DCM/hexane, yellow plates (1.55 g, 73%); m.p. 199-201°C (dec); Found: C, 75.62; H, 6.32; N, 1.84. C 46 H 46 BNO 4 S-0.5H 2 O requires C, 75.79; H, 6.50; N, 1.92.; m/z 400.1586; o C 22 H 26 NO 4 S (cation) requires 400.1583.
  • (+)-6-[(1R,2R,3/?,5S)-2,6,6-trimethylbicyclo[3.1.1]hept-3-yI]-5H- dibenzo[c,e]azepinium tetraphenylborate :0 Prepared according to the general procedure from (-)-i s °pi nocam Phenylamine (3.12 g, 20.5 mmol). The product was isolated as yellow plates (8.00 g, 60%); m.p. 212°C (dec); [ ⁇ ] 20 D +22.4 (c 1.00, CH 3 CN); Found: C, 87.81 ; H, 7.20; N, 1.95.
  • the gummy residue which may be obtained is macerated in hot ethanol or methanol.
  • the organic salt may then precipitate but in some rare cases it does so upon slow cooling of the hot alcoholic solution. If solubility problems do arise, small amounts of acetonitrile may be added during this process.
  • Tetraphenylphosphonium monoperoxysulfate (2 eq with respect to the substrate) was dissolved in the desired solvent (2 ml per 0.1 g oxidant) and cooled to the required temperature.
  • the iminium salt as a solution in the solvent (0.5 ml per 0.1 g oxidant).
  • This iminium salt solution was cooled to the same temperature as the solution containing the oxidant and added dropwise over 15-20 min, the temperature of the reaction vessel was monitored to minimize increase in temperature during the addition.
  • the substrate 100 mol%) was also added as a solution in the reaction solvent (0.5 ml per 0.1 g oxidant) in the same manner as the catalyst. The reaction was stirred at the same temperature until the substrate was completely consumed by TLC.
  • Tetraphenylphosphonium monoperoxysulfate Ph 4 P + cr + OxoneTM(2 KHSO 5 :KHSO 4 : K 2 SO 4 ) ⁇ Ph 4 P + (HSO 5 )-
  • OxoneTM triple salt (2 KHSO 5 :KHSO 4 :K 2 SO 4 ) (15.0 g, 48.8 mmol, w.r.t. KHSO 5 ) was dissolved in deionised water (300 ml) in a conical flask (1 L) and kept under magnetic stirring at 10-15°C (water bath). To this solution tetraphenylphosphonium chloride (15.0 g, 40.0mmol) in distilled dichloromethane (300 ml) was gradually added over 5 min. After an additional 30 min, stirring was interrupted, the organic layer was separated and solvent was removed under vacuum at room temperature. The crude white salt was then transferred to a fritted glass funnel and washed with distilled water (2 x 75 ml).
  • the substrate (1.0 g, 5.4 mmol) was also added as a solution in chloroform (24.5 ml) in the same manner as the catalyst. The reaction was stirred at 40°C for 24 h. Diethyl ether (pre-cooled to -40 °C) was then added to precipitate the remaining oxidant. The solution was filtered through Celite. Solvents were removed under reduced pressure to afford a pale yellow oil.
  • Tetraphenylphosphonium monoperoxysulfate (2 eq, 0.768 g, 1.70 mmol) was dissolved in chloroform (16 ml) and cooled to -40°C. To this was added the iminium salt, (+)-[(4S,5S)- 2,2-dimethyl-4-[4-(methylsulfonyl)-phenyl]-1 ,3-dioxan-5-yl]-3,4-dihydroisoquinolinium tetraphenylborate, (10 ol %, 0.061 g, 0.09 mmol) as a solution in chloroform (4 ml).
  • This iminium salt solution was cooled to the same temperature as the solution containing the oxidant and added dropwise over 15-20 min, the temperature of the reaction vessel was monitored to minimize increase in temperature during the addition.
  • the substrate (0.10 g, 0.85 mmol) was also added as a solution in chloroform (4 ml) in the same manner as the catalyst.
  • the reaction was stirred at -40°C for 24 h.
  • Diethyl ether (20 ml) pre-cooled to -40°C) was then added to precipitate the remaining oxidant.
  • the solution was filtered through Celite. Solvents were removed under reduced pressure to afford a pale yellow oil.
  • reaction mixture was then diluted with ice cooled diethyl ether (20 ml per 100 mg substrate) and was immediately followed by the addition of the same volume of water.
  • the aqueous phase was washed 4 times with diethyl ether and the organics are combined, washed with brine and dried. Filtration and evapouration of the solvents furnishes a yellow or light brown residue.
  • Column chromatography was then performed typically using ethyl acetate : Light petroleum 1 :99 to produce the pure epoxide.
  • Ref 1. Aggarwal, V. K.; Wang, M. F. J. Chem. Soc, Chem. Commun., 1996, 191.
  • Ref 4. Page, P. C. B.; Rassias, G. A.; Barros, D.; Ardakani, A.; Buckley, B.; Bethell, D.; Smith, T. A. D.; Slawin, A.
  • Catalyst of the present invention is highly effective, resulting in higher ee's. High ee's are achievable even at very low loading of catalyst.
  • Asymmetric epoxidation of alkenes mediated by an iminium salt catalyst a 1-Phenyl-3,4-dihydronaphthalene oxide To an ice cooled solution of sodium carbonate (0.20 g, 1.96 mmol), in water (1.6 ml), OxoneTM (0.60 g, 0.98 mmol), was added with stirring and the resulting foaming solution was left to stir for 5-10 minutes, so that most of the initial effervescence subsided.
  • the iminium salt (5 mol %, 0.020 g, 0.025 mmol), was then added as a solution in acetonitrile, (0.8 ml), followed by the alkene substrate, (1 equivalent, 0.10 g, 0.49 mmol), also as a solution in acetonitrile (0.8 ml).
  • the suspension was stirred at the same temperature until the substrate was completely consumed by TLC (0.35 h).
  • the reaction mixture was then diluted with ice cooled diethyl ether (20 ml) and immediately followed by the addition of water (20 ml).
  • Tetraphenylphosphonium monoperoxysulfate (2 eq, 0.696 g, 1.54 mmol) was dissolved in chloroform (14 ml) and cooled to -40°C. To this was added the iminium salt (10 mol %,
  • Enantiomeric excesses were determined by 1 H NMR spectroscopy in the presence of (+)-Eu(hfc) 3 (0.1 mol eq) or by chiral HPLC using a Chiracel OD column.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Epoxy Compounds (AREA)

Abstract

There is provided a process for the preparation of oxiranes wherein an optionally substituted alkene is reacted in the presence of a chiral catalyst, an oxidant and an organic solvent characterised in that the oxidant is at least partially soluble in the organic solvent and the oxidant displays low reactivity towards the alkene in the absence of the catalyst. The optionally substituted alkene is preferably an alkene of formula (1): wherein: R1-4 each independently are hydrogen, an optionally substituted aromatic or is saturated hydrocarbyl, an optionally substituted hetrocyclyl, an optionally substituted aromatic or saturated hydrocarbyloxy, an optionally substituted aromatic or saturated hydrocarbylamino, an optionally substituted aromatic or saturated hydrocarbyloxycarbonyl, an optionally substituted aromatic or saturated hydrocarbylaminocarbonyl, nitrile, halide or one or more of R1 & R2, R2 & R3 , R3 & R4 , R1 & R4 optionally being linked in such a way as to form an optionally substituted ring(s). The oxidant is preferably an oxidant of formula (2): A+ HSO5- wherein A+ is a counterion capable of conferring organic solvent solubility. Preferred chiral catalysts of formula (4): wherein: R11 and R12 are each independently an optionally substituted hydrocarbyl group or R11 & R12 are linked in such a way as to form an optionally substituted ring(s); R13 is hydrogen or an optionally substituted hydrocarbyl group; R14 is an optionally substituted hydrocarbyl group; R17 is hydrogen or an optionally substituted hydrocarbyl group; R15 and R16 each independently are hydrogen or an optionally substituted hydrocarbyl group; and 30 X- is a counterion; * is a chiral centre; and *' is a chiral centre when R17 is not hydrogen are provided.

Description

PROCESS FOR USE IN THE PREPARATION OF OXIRANES FROM ALKENES, AND CATALYSTS FOR USE THEREIN
This invention relates to a process for the preparation of oxiranes from alkenes, preferably asymmetrically. There is provided a process for the preparation of oxiranes wherein an optionally substituted alkene is reacted in the presence of a chiral catalyst, an oxidant and an organic solvent characterised in that the oxidant is at least partially soluble in the organic solvent and the oxidant displays low reactivity towards the alkene in the absence of the catalyst. The optionally substituted alkene is preferably an alkene of formula (1):
Figure imgf000003_0001
(1) wherein: R1"4 each independently are hydrogen, an optionally substituted aromatic or saturated hydrocarbyl, an optionally substituted hetrocyclyl, an optionally substituted aromatic or saturated hydrocarbyloxy, an optionally substituted aromatic or saturated hydrocarbylamino, an optionally substituted aromatic or saturated hydrocarbyloxycarbonyl, an optionally substituted aromatic or saturated hydrocarbylaminocarbonyl, nitrile, halide or one or more of R1 & R2, R2 & R3, R3 & R4, R1 & R4 optionally being linked in such a way as to form an optionally substituted ring(s). Preferably R1"4 each independently are hydrogen, an optionally substituted aromatic or saturated hydrocarbyl, an optionally substituted hetrocyclyl, or one or more of R1 & R2, R2 & R3, R3 & R4, R1 & R4 optionally being linked in such a way as to form an optionally substituted ring(s). Preferably at least one of R\ R2, R3 or R4 is selected to be different from the remaining groups, or one or more of R1 & R2, R2 & R3, R3 & R4, R1 & R4 are linked in such a way as to form an optionally substituted unsymmetrical ring(s). Preferably at least one of R\ R2, R3 or R4 is hydrogen, with the remaining R1"4 groups being the same or different. Preferably at least one of R\ R2, R3 or R4 is an aryl group, with the remaining R1"4 being the same or different. When one or more of R\ R2, R3 and R4 are different, preferably the compound of formula (1 ) is a Z (or cis) isomer. Aromatic or saturated hydrocarbyl groups which may be represented by R1"4 independently include alkyl and aryl groups and any combination thereof, such as aralkyl and alkaryl, for example benzyl groups. Alkyl groups which may be represented by R1"4 include linear and branched alkyl groups comprising up to 20 carbon atoms, particularly from 1 to 7 carbon atoms and preferably from 1 to 5 carbon atoms. When the alkyl groups are branched, the groups often comprising up to 10 branch chain carbon atoms, preferably up to 4 branch chain atoms. In certain embodiments, the alkyl group may be cyclic, commonly comprising from 3 to 10 carbon atoms in the largest ring and optionally featuring one or more bridging rings. Examples of alkyl groups which may be represented by R1"4 include methyl, ethyl, propyl, 2-propyl, butyl, 2-butyl, t-butyl and cyclohexyl groups. Aryl groups which may be represented by R1"4 may contain 1 ring or 2 or more fused rings which may include cycloalkyl, aryl or heterocyclic rings. Examples of aryl groups which may be represented by R1"4 include phenyl, tolyl, fluorophenyl, chlorophenyl, bromophenyl, trifluoromethylphenyl, anisyl, naphthyl and ferrocenyl groups. Aromatic or saturated heterocyclic groups which may be represented by R1"4 independently include aromatic, saturated ring systems and may constitute 1 ring or 2 or more fused rings which may include cycloalkyl, aryl or heterocyclic rings. The heterocyclic group will contain at least one heterocyclic ring, the largest of which will commonly comprise from 3 to 7 ring atoms in which at least one atom is carbon and at least one atom is any of N, O, S or P. Examples of heterocyclic groups which may be represented by R "4 include pyridyl, pyrimidyl, pyrrolyl, thiophenyl, furanyl, indolyl, quinolyl, isoquinolyl, imidazoyl and triazoyl groups. Optionally substituted aromatic or saturated hydrocarbyloxy groups which may be represented by R1"4 independently include alkyoxy and aryloxy groups and any combination thereof, such as aralkyloxyl and alkaryloxyl, for example benzyloxy groups. Optionally substituted aromatic or saturated hydrocarbylamino groups which may be represented by R1"4 independently include mono and d-alkylamino and mono and di- arylamino groups and any combination thereof, such as aralkylamino and alkarylamino, for example benzylamino and benzylmethylamino groups. Optionally substituted aromatic or saturated hydrocarbyloxycarbonyl groups which may be represented by R1"4 independently include alkyoxycarbonyl and aryloxycarbonyl groups and any combination thereof, such as aralkyloxycarbonyl and alkaryloxycarbonyl, for example benzyloxycarbonyl groups. Optionally substituted aromatic or saturated hydrocarbylaminocarbonyl groups which may be represented by R1"4 independently include mono- and di-alkyaminocarbonyl and mono and di-arylaminocarbonyl groups and any combination thereof, such as aralkylaminocarbonyl and alkarylaminocarbonyl, for example benzylaminocarbonyl groups. Halides which may be represented by R "4 independently include fluorine, chlorine, bromine and iodine. When any of R1"4 is a substituted aromatic or saturated hydrocarbyl, a substituted heterocyclic group, a substituted aromatic or saturated hydrocarbyloxy, a substituted aromatic or saturated hydrocarbylamino, a substituted aromatic or saturated hydrocarbyloxycarbonyl, a substituted aromatic or saturated hydrocarbylaminocarbonyl, the substituent(s) should be such so as not to adversely affect the rate or stereoselectivety of the reaction. Optional substituents include halogen, cyano, nitro, hydroxy, amino, thiol, acyl, hydrocarbyl, perhalogentated hydrocarbyl, heterocyclyl, hydrocarbyloxy, mono or di-hydrocarbylamino, hydrocarbylthio, esters, carbonates, amides, sulphonyl and sulphonamido groups wherein the hydrocarbyl groups are as defined for R1 above. One or more substituents may be present. Where the substituted aromatic or saturated hydrocarbyl group is fully substituted by halogen substituents, the group is referred to as a perhalogenated aromatic or saturated hydrocarbyl group. Perhalogenated aromatic or saturated hydrocarbyl groups which may be represented by R1"4 independently include perhalogenated alkyl and aryl groups, and any combination thereof, such as aralkyl and alkaryl groups. Examples of perhalogenated alkyl groups which may be represented by R1"4 include -CF3 and -C2F5. When any of R1 & R2, R2 & R3, R3 & R\ R1 & R4 are linked in such a way that when taken together with the carbon atoms to which they are attached that an optionally substituted ring is formed, the ring atoms may in addition to carbon atoms may optionally comprise one or more heteroatoms, preferably selected from N, O, S or P. Preferably, when any of R1 & R2, R2 & R3, R3 & R4, R1 & R4 are linked in such a way that when taken together with the carbon atoms to which they are attached that an optionally substituted ring is formed, the rings atoms are carbon atoms. Preferably, when any of R1 & R2, R2 & R3, R3 & R4, R1 & R4 are linked in such a way that when taken together with the carbon atoms to which they are attached that an optionally substituted ring is formed, that the ring is a 5, 6 or 7 membered rings. When any of R1 & R2, R2 & R3, R3 & R4, R1 & R4 are linked in such a way that when taken together with the carbon atoms to which they are attached that an optionally substituted ring is formed, the optional substituents include halogen, cyano, nitro, hydroxy, amino, thiol, acyl, hydrocarbyl, perhalogentated hydrocarbyl, heterocyclyl, hydrocarbyloxy, mono or di-hydrocarbylamino, hydrocarbylthio, esters, carbonates, amides, sulphonyl and sulphonamido groups wherein the hydrocarbyl groups are as defined for R1 above. One or more substituents may be present. Examples of such compounds of formula (1 ) include:
Figure imgf000006_0001
Although ozone is not considered to show the required level of solubility in organic solvents, there are many oxidants which show appropriate levels of solubility in organic solvents. However, only those oxidants which also do not display high levels of background epoxidation of the alkene in the absence of the catalyst find use in the process of the present invention. Oxidants which show appropriate levels of solubility in organic solvents and which show no appreciable levels of epoxidation of the alkene in the absence of the catalyst in the range 0°C to -78°C are preferred. Preferred oxidants include oxidants of formula (2):
A+ HSO5 " (2)
wherein A+ is a counterion capable of conferring organic solvent solubility. Preferred counterions which are represented by A+ include (PR6R7R8R9)+ wherein R6"9 are optionally substituted aryl groups. Optionally substituted aryl groups are as described above for R1"4. More preferably the oxidants are compounds of formula (3):
Figure imgf000006_0002
(3) wherein: R10 is hydrogen, a polyfluorinated alkyl, a resin or a linker bound to a resin. Polyfluorinated alkyl groups which may be represented by R10 include partial and fully halogenated alkyl groups, preferably fully halogenated alkyl group. Examples of polyfluorinated alkyl groups include CF3. Most preferably, R 0 is hydrogen. The chiral catalyst is often a chiral iminium salt. The chiral catalyst is preferably a chiral iminium salt of formula (4):
Figure imgf000007_0001
wherein: R11 and R12 are each independently an optionally substituted hydrocarbyl group or R11 & R12 are linked in such a way as to form an optionally substituted ring(s); R13 is hydrogen or an optionally substituted hydrocarbyl group; R14 is an optionally substituted hydrocarbyl group; R17 is hydrogen or an optionally substituted hydrocarbyl group; R15 and R16 each independently are hydrogen or an optionally substituted hydrocarbyl group; and X" is a counterion; * is a chiral centre; and *' is a chiral centre when R17 is not hydrogen. Preferably, R11 & R12 are linked in such a way as to form an optionally substituted ring(s); R13 is hydrogen; R14 is an optionally substituted hydrocarbyl group; R17 is hydrogen or an optionally substituted hydrocarbyl group; R15 and R16 each independently are hydrogen or an optionally substituted hydrocarbyl group; and * is a chiral centre Hydrocarbyl groups which may be represented by R11"17 independently include alky and aryl groups and any combination thereof, such as aralkyl and alkaryl, for example benzyl groups. Alkyl groups which may be represented by R11"17 include linear and branched alkyl groups comprising up to 20 carbon atoms, particularly from 1 to 7 carbon atoms and preferably from 1 to 5 carbon atoms. When the alkyl groups are branched, the groups often comprising up to 10 branch chain carbon atoms, preferably up to 4 branch chain atoms. In certain embodiments, the alkyl group may be cyclic, commonly comprising from 3 to 10 carbon atoms in the largest ring and optionally featuring one or more bridging rings. Examples of alkyl groups which may be represented by R1 "17 include methyl, ethyl, propyl, 2-propyl, butyl, 2-butyl, t-butyl and cyclohexyl groups. Aryl groups which may be represented by R11"17 may contain 1 ring or 2 or more fused rings which may include cycloalkyl, aryl or heterocyclic rings. Examples of aryl groups which may be represented by R11"17 include phenyl, tolyl, fluorophenyl, chlorophenyl, bromophenyl, trifluoromethylphenyl, anisyl, naphthyl and ferrocenyl groups. Aromatic or saturated heterocyclic groups which may be represented by R11"17 independently include aromatic, saturated ring systems and may constitute 1 ring or 2 or more fused rings which may include cycloalkyl, aryl or heterocyclic rings. The heterocyclic group will contain at least one heterocyclic ring, the largest of which will commonly comprise from 3 to 7 ring atoms in which at least one atom is carbon and at least one atom is any of N, O, S or P. Examples of heterocyclic groups which may be represented by R 1"17 include pyridyl, pyrimidyl, pyrrolyl, thiophenyl, furanyl, indolyl, quinolyl, isoquinolyl, imidazoyl and triazoyl groups. When any of R11"17 is a substituted aromatic or saturated hydrocarbyl or a substituted heterocyclic group, the substituent(s) should be such so as not to adversely affect the rate or stereoselectivety of the reaction. Optional substituents include halogen, cyano, nitro, hydroxy, amino, thiol, acyl, hydrocarbyl, perhalogentated hydrocarbyl, heterocyclyl, hydrocarbyloxy, mono or di-hydrocarbylamino, hydrocarbylthio, esters, carbonates, amides, sulphonyl and sulphonamido groups wherein the hydrocarbyl groups are as defined for R1 above. One or more substituents may be present. Where the substituted aromatic or saturated hydrocarbyl group is fully substituted by halogen substituents, the group is referred to as a perhalogenated aromatic or saturated hydrocarbyl group. Perhalogenated aromatic or saturated hydrocarbyl groups which may be represented by R11"17 independently include perhalogenated alkyl and aryl groups, and any combination thereof, such as aralkyl and alkaryl groups. Examples of perhalogenated alkyl groups which may be represented by R11"17 include -CF3 and -C2F5. When R11& R12 are linked in such a way that when taken together with the nitrogen and carbon atoms to which they are attached that an optionally substituted ring is formed, it is preferred that these be 5, 6 or 7 membered rings. Optional substituents include halogen, cyano, nitro, hydroxy, amino, thiol, acyl, hydrocarbyl, perhalogentated hydrocarbyl, heterocyclyl, hydrocarbyloxy, mono or di-hydrocarbylamino, hydrocarbylthio, esters, carbonates, amides, sulphonyl and sulphonamido groups wherein the hydrocarbyl groups are as defined for R1 above. One or more substituents may be present. Catalysts of Formula (4) may optionally be attached to a resin. Preferably attachment to a resin via an optional linker may suitably achieved by substitution on one or more of R11, R12, R14 or R17. Counterions which may be represented by X" include anions which confer organic solubility, preferably delocalised anions, more preferably[BPh4]\ Examples of counterions which may be represented by X include [BF4]', [CF3SO3]-, [BPh4]-, [PF6]' and [CIO4]-. Preferred catalysts are compounds of formula (4a), (4b), (4c) and (4d):
Figure imgf000009_0001
(4a) (4b) (4c) (4d)
wherein: R14 is an optionally substituted aryl group, preferably an optionally substituted phenyl group; R 5 is hydrogen or C1-4 alkyl group, preferably hydrogen or a methyl group, most preferably a methyl group; R16 is hydrogen or C1-4 alkyl group, preferably hydrogen or a methyl group, most preferably a methyl group; R18 and R19 are each independently hydrogen or a C1-4 alkyl group, preferably hydrogen or a methyl group, most preferably both are methyl groups; R20 is preferably an electron donating group, more preferably dihydrocarbylamino; and is a counterion, preferably [BF4]_, [CF3SO3]-, [BPh4]", [PF6]_ and [CIO4]\ Preferred are catalysts of compound of formula (4a), (4b), (4c) or (4d) wherein R14 is an optionally substituted phenyl group; R15 is hydrogen or a methyl group; R16 is hydrogen or a methyl group; R18 and R19 are each independently hydrogen or a methyl group; R20 is a dihydrocarbylamino group; and X" is [BPh4]", [PF6]" or [CIO4]". Highly preferred are catalysts of Formula (4a) wherein R14 is an unsubstituted phenyl group and R15 and R16 are methyl groups, and catalysts of Formula (4c) wherein R14 is a C6H4SO2CH3 group and R15 and R16 are methyl groups. Organic solvents suitable for use in the process of present invention include polar and non-polar organic solvents, especially hydrocarbons, for example benzene, toluene and xylene, halogented hydrocarbons, for example choloroform and methylene chloride, ethers, for example tetrahydrofuran, t-butyl methyl ether and diglyme, alcohols, such as C4.8 aliphatic alcohols, especially pentanol and hexanol and isomers thereof, cyclohexanol, acetonitrile, and polar aprotic solvents, for example N-methyl pyrrolidone, dimethylformamide, N,N-dimethylacetamide or dimethyl sulphoxide, and mixtures thereof. Preferred organic solvents are acetonitrile, methylene chloride and chloroform. The choice of organic solvent or organic solvent mixtures is typically influenced by the solubility of the substrate, the catalyst and the oxidant. Unusually, for certain substrates, it has been found that the choice of solvent may influence the stereospecificity of the reaction. For example, when the substrate is a trans tri-substituted alkene, chlorinated solvents leads to a predominance of one enatiomeric 5 product, whereas acetonitrile leads to a predominance of the other enantiomeric product. Usually it is preferred to operate in substantial absence of water, but water does not appear to inhibit the reaction. Although the use of base is not required in the substantial absence of water, the process of the present invention may optionally be carried out in the presence of a base.0 Suitably the process is carried out at temperatures in the range of from minus 85 to plus 50°C, preferably from minus 78 to plus 35°C and more preferably from minus 40 to plus 25°C. The initial concentration of the alkene, a compound of formula (1 ), is suitably in the range 0.1 to 100 %wt/v and, for convenient larger scale operation, can be for example up5 to 20%wt/v more especially 0.5 to 10% wt v. The molar ratio of the substrate to catalyst is suitably no less than 10:1 and can be up to 1000:1 , preferably between 10:1 and 100:1 and more preferably between 20:1 and 1 :1. The oxidant is preferably employed in a molar excess over the substrate, especially about a 2 fold excess. Reaction times are typically in the range of from 3 min to 24h, especially up to 24h and conveniently about0 4h. After the reaction is complete, the resulting mixture is worked up by standard procedures. Typically, addition of diethyl ether results in precipitation of the oxidant which is removed by filtration leaving the product in solution. The invention will now be described, without limitation, by the following examples.5 EXPERIMENTAL
PREPARATION OF AMINE INTERMEDIATES: General procedure for the formation of the formate protected 5-amino-1,3-dioxanes o from commercially available amino diols:
The amino diol (1.0 equiv.) was dissolved in methanol (10 ml/g) and methyl formate (1.1 equiv.) was added with sodium methoxide (10 mol%). The reaction was left to stir for 3.5h and the solvent removed under reduced pressure. The crude yellow oil was 5 dissolved with CSA (10 mol%) in acetone (50 ml/g) and 2,2-dimethoxypropane (10.0 equiv.). The reaction was left to stir for up to 4h and monitored by thin layer chromatography (TLC). Solvents were removed under reduced pressure and the residue re-dissolved in ethyl acetate, which was washed with sat. aq. sodium hydrogen carbonate. The organics were dried (MgSO4) and solvents removed under reduced pressure.
N-[(4S,5S)-2,2-Dimethyl-4-[4-nitro-phenyl]-1,3-dioxan-5-yl]formamide:
Prepared according to the general procedure from (1S,2S)-(+)-2-amino-1-(4-nitrophenyl)- 1 ,3-propandiol (1.00 g, 4.71 mmol). Colourless oil (1.12 g, 85%); [α]D +3.5° (c 1.02, CHCI3); vmax(film) /cm"1 1674, 1520, 1346, 856; δH (250 MHz; CDCI3) 1.55 (3H, s), 1.59 (3H, s), 3.83 (1 H, dd, J 12.1 , 1.7 Hz), 4.24 (1 H, dd, J 12.1 , 1.8 Hz), 4.40 (1 H, m,), 5.26 (1 H, d, J 1.0 Hz), 7.50 (2H, d, J 8.9 Hz), 7.91 (1H, s), 8.15 (2H, d, J 8.9 Hz); δc (62.5 MHz; CDCI3) 18.81 , 29.29, 45.38, 64.86, 71.91 , 100.70, 123.72, 126.79, 145.80, 147.80, 160.62. m/z 298.1399; C13H16N2O5 (M+NH4) requires 298.1403.
Λ/-[(4S,5S)-2,2-Dimethyl-4-[4-(methylsulfanyl)-phenyl]-1,3-dioxan-5-yl]formamide:
Prepared according to the general procedure from (1 S,2S)-(+)-2-amino-1-(4- methylthiophenyl)-1 ,3-propandiol (5.00 g, 23.4 mmol). Colourless oil (5.50 g, 84%); m/z 281.1081 ; C14H19NO3S (M+) requires 281.1085.
Λ -[(4S,5S)-2,2-Dimethyl-4-[4-(methylsulfonyI)-phenyl]-1,3-dioxan-5-yl]formamide:
Λ/-[(4S,5S)-2,2-Dimethyl-4-[4-(methylsulfanyl)-phenyl]-1 ,3-dioxan-5-yl]formamide (4.0 g, 14.2 mmol) was dissolved in dichloromethane (100 ml) and cooled to 0°C. To this solution was added m-CPBA (2.2 eq, 7.03 g, 31.0 mmol) as a solution in chloroform (20 ml), dropwise over 10 min. The reaction was then left to stir for 2 h. The reaction mixture was transferred to a separating funnel and washed with sat. aq. sodium hydrogen carbonate (2 x 40 ml), brine (2 x 40 ml) and dried (MgSO4). Solvents were removed under reduced pressure to yield a colourless oil. Crystallized from chloroform/diethyl ether, colourless crystals (3.80 g, 85%); m.p. 146-147°C; m/z 314.1058; C14H19NO5S (M+H) requires 314.1062.
(2S)-terf-ButoxycarbonyIamino-3-(4-methoxy-phenyl)-propionic acid methyl ester:
A solution of (2S)-terf-Butoxycarbonylamino-3-(4-hydroxy-phenyl)-propionic acid (8.00 g, 28.5 mmol) in dimethylformamide (80 ml) was treated with ground potassium hydroxide (1.72 g, 31.3 mmol) and iodomethane (1.95 ml, 31.3 mmol) (in 20 ml dimethylformamide) was added dropwise over 5 min at 0°C. The reaction was stirred at room temperature for 30 min and, after this time period, additional ground potassium hydroxide (1.72 g, 31.3 mmol) and iodomethane (1.95 ml, 31.3 mmol) (in 20 ml dimethylformamide) were added at 0°C. The reaction was then left to stir for 3 h. The solution was poured onto ice (150 ml) and extracted with ethyl acetate (3 x 75 ml). The organic layers were washed with water (3 x 50 ml), brine (2 x 50 ml) and dried (MgSO4). The solvent was removed under reduced pressure to yield a colourless oil. Crystallization was achieved from ethyl acetate/light petroleum, to give colourless crystals (6.5 g, 74%); m.p. 52-53 °C; m/z 309; C16H23NO5 requires 309.15762.
Methyl (4S,5/?)-5-[4-(methyloxy)phenyI]-2-oxo-1 ,3-oxazolane-4-carboxylate :
(2S)-fert-Butoxycarbonylamino-3-(4-methoxy-phenyl)-propionic acid methyl ester (5.0 g, 16.2 mmol) was dissolved in CH3CN (200 ml). To this was added K2S2O8 (8.75 g, 32.4 mmol) as a solution in water (210 ml) and CuSO4 (0.52 g, 3.2 mmol) also as a solution in water (50 ml). The reaction mixture was then heated to 70°C, under a blanket of N2, for 3 h. The solution was allowed to cool and extracted with ethyl acetate (3 x 150 ml), dried (MgSO4), concentrated under reduced pressure to yield a crude dark yellow oil. Column chromatography eluting with ethyl acetate/light petroleum (1:10-1:1) afforded a colourless solid, which was recrystallized from ethyl acetate/light petroleum to afford colourless crystals (2.10g, 52%); m.p. 94-96°C; m/z 251.0794; C12H13NO5 (M+) requires 251.0794.
(4R,5/?)-4-(hydroxymethyl)-5-[4-(methyloxy)phenyl]-1,3-oxazolan-2-one: Methyl (4S,5R)-5-[4-(methyloxy)phenyl]-2-oxo-1 ,3oxazolane-4-carboxylate (2.20 g, 8.8 mmol) was dissolved in ethanol (25 ml) and cooled to 0°C. To this was added dropwise NaBH4 (0.70 g, 19.3 mmol) as a solution in ethanol (8 ml). After the addition was complete the ice bath was removed and the reaction stirred at room temperature for 45 min. The reaction was cooled down to 0°C and cone. HCI (1.5 ml) was added, followed by water (15 ml). The ethanol was evaporated under reduced pressure and the remaining aqueous solution extracted with ethyl acetate (3 x 50 ml). The organics were dried (MgSO4) and solvents removed to afford a crude off white solid, which was recrystallized from ethyl acetate/light petroleum, to afford colourless crystals (1.75 g, 90%); m.p. 140-142°C; C11H13NO4 (M+) requires 223.0845.
(1 f?,2R)-(-)-2-Amino-1 -(4-methyloxy-phenyl)-1 ,3-propanediol:
4-Hydroxymethyl-5-(4-methoxy-phenyl)-oxazolidin-2-one (1.65 g, 7.4 mmol) was suspended in 1 M NaOH (40 ml) and heated at reflux for 30 min. The reaction was allowed to cool to room temperature and extracted with ethyl acetate (8 x 30 ml). The organics were dried (MgSO4) and solvents removed to afford a colourless solid, recrystallized from methanol/diethyl ether (1.33 g, 91%); m.p. 132-134°C; m/z 198.1125; C10H15NO3 (M+H) requires 198.1130.
Λ/-{(4R,5R)-2,2-Dimethyl-4-[4-(methyloxy)-phenyl]-1,3-dioxan-5-yl}formamide: (1R,2ft)-(-)-2-Amino-1-(4-methyloxy-phenyl)-1 ,3-propanediol (1.2 g, 6.1 mmol) was dissolved in methanol (25 ml) and methyl formate (0.45 ml, 7.3 mmol) was added with sodium methoxide (0.1 ml). The reaction was left to stir for 3.5 h and the solvent removed under reduced pressure. The crude yellow oil was then dissolved in acetone (60 ml), 2,2-dimethoxypropane (10 equiv.) and boron-trifluoride-diethyletherate was added until pale yellow colour persisted (ca 0.2 ml). The reaction was then left to stir for 45 min. Solvents were again removed under reduced pressure and the residue re-dissolved in ethyl acetate, which was washed with sat. aq. sodium hydrogen carbonate. The organics were dried (MgSO4) and solvents removed to yield a pale yellow oil (1.21 g, 75%); m/z 266.1390; C14H19NO4 (M+H) requires 266.1392.
General procedure for the deprotection of formamides with hydrazine hydrate:
The formate protected acetonide was dissolved in aq. hydrazine hydrate (85%) (20 ml/g) and the solution heated under reflux for 2.5 h. The solution was allowed to cool to room temperature and extracted with ethyl acetate (3 x 20 ml/g). The organic layers were washed with water (2 x 20 ml/g), dried (MgSO4) and solvents removed under reduced pressure.
(4S,5S)-2,2-dimethyl-4-[4-nitro-phenyl]-1,3-dioxan-5-amine: Prepared according to the general procedure from Λ/-[(4S,5S)-2,2-Dimethyl-4-[4-nitro- phenyl]-1 ,3-dioxan-5-yl]formamide (4.00 g, 14.9 mmol), except reaction heated under reflux for 1 h. Chromatography performed eluting with ethylacetate. Pale yellow plates. (2.80 g, 78%); mp 117-119°C; [α]D 20 +66.2° (c 1.13, CHCI3); Found: C, 57.05; H, 6.51 ; N, 10.77. C12H16N2O4 requires C, 57.13; H, 6.39; N, 11.10.; vmax(film) /cm"1 1605, 1520, 1350, 1196, 1080, 941 , 856; δH (250 MHz; CDCI3) 1.56 (6H, s), 2.84 (1 H, q, J 1.9 Hz), 3.86 (1 H, dd, J 11.8, 1.9 Hz), 4.31 (1 H, dd, J 11.8, 2.3 Hz), 5.17 (1 H, d, J 0.7 Hz), 7.49 (2H, d, J 7.5 Hz), 8.22 (2H, d); δc (100 MHz; CDCI3) 18.59, 29.66, 49.42, 66.32, 73.42, 99.57, 123.63, 126.66, 147.17, 147.29; m/z 253.1191 ; C12H16N2O4 (M+H) requires 253.1188.
(4S,5S)-2,2-dimethyl-4-[4-(methylsulfanyl)-phenyl]-1 ,3-dioxan-5-amine:
Prepared according to the general procedure from Λ/-[(4S,5S)-2,2-Dimethyl-4-[4- (methylsulfanyl)-phenyl]-1 ,3-dioxan-5-yl]formamide (1.50 g, 5.34 mmol). Colourless oil (1.28 g, 95%); m/z 253.1137; C13H19NO2S (M+) requires 253.1137.
(4S,5S)-2,2-dimethyl-4-[4-(methylsulfonyl)-phenyl]-1 ,3-dioxan-5-amine:
Prepared according to the general procedure from Λ/-[(4S,5S)-2,2-Dimethyl-4-[4- (methylsulfonyl)-phenyl]-1 ,3-dioxan-5-yl]formamide (1.80 g, 5.8 mmol). Product isolated as a colourless oil, crystallized from diethyl ether/ethylacetate. Colourless crystals (1.59 g, 96%); m.p. 120-122 °C; m/z 285.1028; C13H19NO4S (M+) requires 285.1035.
(4R,5/?)-2,2-dimethyI-4-[4-(methyloxy)-phenyI]-1,3-dioxan-5-amine:
Prepared according to the general procedure from Λ/-[(4R,5R)-2,2-Dimethyl-4-[4- (methyloxy)-phenyl]-1 ,3-dioxan-5-yl]formamide (0.70 g, 2.6 mmol). Colourless oil. (0.59 g, 95%); m/z 238.1443; C13H19NO3 (M+H) requires 238.1443. PREPARATION OF CATALYSTS:
General procedure for the synthesis of dihydroisoquinolinium salts from 2-(2- bromoethyl) benzaldehyde and primary amines: A solution of the amine in ethanol, (10 ml per g of amine, 1 equivalent), was added dropwise via a stoppered, pressure equalising, dropping funnel, to an ice cooled, one- neck flask, containing 2-(2-bromoethyl) benzaldehyde, (1.60 equivalents, 1.10 if distilled previously). After the addition was complete the dropping funnel was removed and replaced by a stopper to contain the hydrogen bromide generated temporarily in the reaction. The reaction mixture was stirred overnight while attaining ambient temperature. Sodium tetraphenylborate, (or any other anion exchanging salt, 1.10 equivalents), in the minimum amount of acetonitrile, was added in one portion to the reaction mixture and after 5 minutes of stirring, the organic solvents are removed under reduced pressure. Ethanol was added to the residue, followed by water. The resulting solid was collected by filtration and washed with additional ethanol followed by diethyl ether. If no solid materialises after the addition of the water the suspension was allowed to settle and the ethanol/water phase was decanted off. The gummy residue which may be obtained, was macerated in hot ethanol or methanol. The organic salt may then precipitate but in some rare cases it does so upon slow cooling of the hot alcoholic solution. If solubility problems do arise, small amounts of acetonitrile may be added during this process.
(+)-2-[(4S,5S)-2,2-dimethyl-4-phenyl-1,3-dioxan-5-yI]-3,4-dihydroisoquinolinium tetraphenylborate:'
Prepared according to the general procedure. Yield 75%, recrystallized from acetone/diethyl ether, yellow solid, m.p. 169-170°C; δH (250 MHz; CD3CN), 1.65 (3H, s), 1.94 (3H, s), 2.39-2.48 (1 H, m), 2.70-2.82 (1 H, m) 3.25-3.40 (1 H, m), 3.81-3.97 (1 H, m), 4.06 (1H, m), 4.30 (1 H, d, J 13.7 Hz), 4.58 (1 H, dd, J 13.7, 3.1 Hz), 5.70 (1 H, d, J 2.8 Hz), 6.81 (4H, t, J 7.2 Hz), 7.35-7.40 (6H, m), 7.46 (1 H, t, J 7.3 Hz), 7.65-7.74 (2H, m), 8.92 (1H, s); δc (62.50 MHz; CD3CN) 17.98, 24.06, 28.68, 51.55, 61.44, 65.46, 70.72, 104.88, 121.85, 124.29, 125.44, 125.72, 128.14, 128.46, 128.62, 128.04, 134.39, 135.79, 136.97,
137.68, 138.72, 163.51 , 167.48; m/z 322.1809; C21H24NO2 (cation) requires 322.1807.
(-)-2-[(4R,5 ?)-2,2,4-Trimethyl-1,3-dioxan-5-yI]-3,4-dihydroisoquinolinium tetraphenylborate: Prepared according to the general procedure from (1R,2R)-2,2,4-Trimethyl-[1,3]dioxan-5- yl-amine (0.75 g, 2.96 mmol). Recrystallized from DCM/hexane, yellow plates (1.13 g, 66%); Recrystallized from acetone/ethyl acetate. Yield (0.149 g, 66%); mp 164-165°C (dec); m/z 260.1655; C16H22NO2 (cation) requires 260.1651. (+)-2-[(4S,5S)-2,2-dimethyl-4-(1-methylethyl)-1,3-dioxan-5-yl]-3J4- dihydroisoquinolinium tetraphenylborate: Prepared according to the general procedure from (4S,5S)-2,2-dimethyl-4-(1- methylethyl)-1 ,3-dioxan-5-amine (0.05 g, 0.29 mmol). Recrystallized from acetone/diethyl 5 ether, yellow plates (0.120 g, 70%); mp 166-167°C (dec); m/z 288.1959; C18H26NO2 (cation) requires 288.1964.
(+)-[(4S,5S)-2,2-dimethyl-4-[4-(nitro)-phenyl]-1,3-dioxan-5-yl]-dihydroisoquinolinium tetraphenylborate:0 Prepared according to the general procedure from (+)-(4S,5S)-2,2-dimethyl-4-[4-(nitro)- phenyl]-1 ,3-dioxan-5-amine (0.19 g, 0.8 mmol). Recrystallized from DCM/hexane, yellow plates (0.36 g, 74%); m.p. 176-178 °C (dec); Found C, 77.73; H, 6.23; N, 4.00; C45H43BN2O4-0.5H2O requires: C, 77.66; H, 6.38; N, 4.03.; m/z 367.1658; C21H23N2O4 (cation) requires 367.1658.5 (+)-[(4S,5S)-2,2-dimethyl-4-[4-(methylsulfanyl)-phenyl]-1,3-dioxan-5-yI]- dihydroisoquinolinium tetraphenylborate: Prepared according to the general procedure from (4S,5S)-2,2-dimethyl-4-[4- (methylsulfanyl)-phenyl]-1 ,3-dioxan-5-amine (0.50 g, 2.0 mmol). Recrystallized from0 DCM/hexane, yellow plates (1.00 g, 73%); m.p. 146-148°C (dec); Found: C, 79.05; H, 6.59; N, 1.93. C46H46BNO2S-0.5H2O requires C, 79.27; H, 6.66; N, 2.01.; m/z 368.1682; C22H26NO2S (cation) requires 368.1684.
(+)-[(4S,5S)-2,2-dimethyl-4-[4-(methylsulfonyl)-phenyl]-1,3-dioxan-5-yl]-3,4-5 dihydroisoquinolinium tetraphenylborate: Prepared according to the general procedure from (4S,5S)-2,2-dimethyl-4-[4- (methylsulfonyl)-phenyl]-1 ,3-dioxan-5-amine (0.75 g, 2.96 mmol). Recrystallized from DCM/hexane, yellow plates (1.55 g, 73%); m.p. 199-201°C (dec); Found: C, 75.62; H, 6.32; N, 1.84. C46H46BNO4S-0.5H2O requires C, 75.79; H, 6.50; N, 1.92.; m/z 400.1586; o C22H26NO4S (cation) requires 400.1583.
H-[(4/?,5 ?)-2,2-dimethyl-4-[4-(methyIoxy)-phenyl]-1,3-dioxan-5-yl]- dihydroisoquinolinium tetraphenylborate: Prepared according to the general procedure (-)-(4R,5R)-2,2-dimethyl-4-[4-(methyloxy)-5 phenyl]-1 ,3-dioxan-5-amine (0.40 g, 1.7 mmol). Recrystallized from DCM/hexane, yellow plates (0.83 g, 74%); m.p. 171-173°C (dec); m/z 352.1915; C22H26NO3 (cation) requires 352.1913.
General procedure for the synthesis of 5H-dibenzo[c,e]azepinium salts from 2-[2- (bromomethyl)phenyljbenzene carbaldehyde and primary amines:
A solution of the amine in ethanol, (10 ml per g of amine, 1 equivalent), was added dropwise via a stoppered, pressure equalising, dropping funnel, to an ice cooled, one- neck flask, containing a solution of 2-[2-(bromomethyl)phenyl]benzene carbaldehyde, (1.10 equiv.) in ethanol (10 ml/g carbaldehyde). After the addition was complete the dropping funnel was removed and replaced by a stopper to contain the hydrogen bromide generated temporarily in the reaction. The reaction mixture was stirred overnight while attaining ambient temperature. Sodium tetraphenylborate, (or any other anion exchanging salt, 1.10 equivalents), in the minimum amount of acetonitrile, was added in one portion to the reaction mixture and after 5 minutes of stirring, the organic solvents are removed under reduced pressure. Ethanol was added to the residue, followed by water. The resulting solid was collected by filtration and washed with additional ethanol followed by diethyl ether. If no solid materialises after the addition of the water the suspension is allowed to settle and the ethanol/water phase is decanted off. The gummy residue which may be obtained, is macerated in hot ethanol or methanol. The organic salt may then precipitate but in some rare cases it does so upon slow cooling of the hot alcoholic solution. If solubility problems do arise, small amounts of acetonitrile may be added during this process.
5,7-dihydrodibenzo[c,e]oxepine:
A suspension of 2,2'-biphenyl dimethanol, (4.22 g, 19.5 mmol), in hydrobromic acid (60 ml, 24% in water), was heated to 100°C for 40 min. The cloudy solution was then allowed to cool and the aqueous phase extracted with diethyl ether (3 x 50 ml). The organic layers are then washed with brine (50 ml), sat. aq. Sodium hydrogen carbonate and dried (MgSO4). Solvent was removed to yield a colourless solid. Recrystallized from ethyl acetate/light petroleumto give colourless crystals, (3.25 g, 85%); m.p. 71°C; vmax(film) /cm" 1 1567, 1197, 1073, 1042, 903, 891 , 754, 602; δH (400 MHz; CDCI3) 4.35 (4H, s), 7.23- 7.56 (8H, m); δc (100 MHz; CDCI3) 67.53, 127.46, 128.24, 128.91 , 129.69, 135.16, 141.19; m/z 196.0887; C14H12O (M+) requires 196.0888.
2-[2-(bromomethyl)phenyl]benzene carbaldehyde:
To an ice cooled solution of 5,7-dihydrodibenzo[c,e]oxepine (2.00 g, 10.2 mmol), in carbon tetrachloride (50 ml), in a round bottom flask equipped with a reflux condenser was added molecular bromine (1.76 g, 11.0 mmol), in carbon tetrachloride (6 ml), dropwise over 5 min (the reaction turns deep red). The cooling bath was removed and the reaction mixture irradiated with ultra violet light for 5 h (after 20 min solution turns pale yellow, indicative of complete consumption of bromine). The resultant solution was evaporated under reduced pressure, then diluted with diethyl ether, washed with sat. aq. Sodium carbonate, brine and dried (MgSO4). Solvents were removed under reduced pressure to yield a orange oil. Crystallized from ethyl acetate/light petroleum as colourless crystal. (1.80 g, 64%); m.p. 56-58°C; vmax(nujol) /cm"1 1694, 1594, 1255, 1221 , 1197, 761 ; δH (400 MHz; CDCI3) 4.21 (2H, dd, J 40.0, 10.1 Hz), 7.12-7.98 (8H, m), 9.65 (1 H, s); δc (100 MHz; CDCIs), 33.83, 129.96, 130.88, 131.02, 131.40, 133.00, 133.05, 133.39, 5 135.95, 136.41 , 138.28, 140.16, 145.63, 194.08; m/z 275.9977 (81Br isotope); C^HnBrO (M+) requires 275.9974.
(+)-6-[(1R,2R,3/?,5S)-2,6,6-trimethylbicyclo[3.1.1]hept-3-yI]-5H- dibenzo[c,e]azepinium tetraphenylborate :0 Prepared according to the general procedure from (-)-is°pinocamPhenylamine (3.12 g, 20.5 mmol). The product was isolated as yellow plates (8.00 g, 60%); m.p. 212°C (dec); [α]20 D +22.4 (c 1.00, CH3CN); Found: C, 87.81 ; H, 7.20; N, 1.95. C48H48BN«0.3H2O requires C, 87.79; H, 7.37; N, 1.95.; vmax(nujol) /cm'1 1630, 1599, 1580, 1557, 1209, 756, 705, 612; δH (400 MHz; DMSO-d6, 80°C) 1.02 (3H, d, J 11.28 Hz), 1.14 (3H, s), 1.35 (3H,5 s), 1.48 (1H, d, J 16.8 Hz), 2.02 (1 H, td, J 9.3, 2.6 Hz), 2.10-2.31 (2H, m), 2.55-2.74 (3H, m), 4.84-5.12 (3 H, m), 6.80 (4H, t, J 11.4 Hz), 6.93 (8H, t, J 11.8 Hz), 7.20-7.29 (8H, m), 7.61-7.92 (6H, m), 8.02 (1 H, td, J 11.64, 2.24 Hz), 8.07-8.16 (1 H, m), 9.69 (1 H, s); δc (100 MHz; DMSO-d6, 80°C) 19.92, 23.76, 28.97, 33.69, 34.80, 40.00, 41.12, 42.15, 48.36, 53.99, 74.28, 122.23, 125.96, 127.77, 129.41 , 129.65, 129.94, 130.31 , 130.69, 131.08,0 131.12, 135.41 , 135.74, 136.55, 137.93, 141.90, 164.50, 171.15; m/z 330.2228; C24H28N (cation) requires 330.2222.
(-)-2-[(4S,5S)-2,2-dimethyl-4-phenyl-1,3-dioxan-5-yl]-5H-dibenzo[c,e]azepinium tetraphenylborate:5 Prepared according to the general procedure from (+)-(4S,5S)-2,2-Dimethyl-4-phenyl-1 ,3- dioxan-5-amine (3.85 g, 18.8 mmol). The product was isolated as yellow plates (9.00 g, 68%); m.p. 187-188°C (dec); Found C, 85.23; H, 6.52; N, 1.96. C50H46BNO2 requires C, 85.34; H, 6.59; N, 1.99.; m/z 384.1968; C26H26NO2 (cation) requires 384.1964.
o (-)-2-[(4S,5S)-2,2-Dimethyl-4-[4-(nitro)-phenyI]-1 ,3-dioxan-5-yl]-5H- dibenzo[c,e]azepinium tetraphenylborate: Prepared according to the general procedure from (+)-(4S,5S)-2,2-Dimethyl-4-[4-(nitro)- phenyl]-1 ,3-dioxan-5-amine (0.30 g, 1.19 mmol). The product was isolated as yellow plates (0.57 g, 64%); m.p. 209-210°C (dec); Found: C, 85.23; H, 6.52; N, 1.96.5 C50H46BNO2 requires C, 85.34; H, 6.59; N, 1.99.; m/z 429.1815; C26H25N2O4 (cation) requires 429.1814.
(-)-2-[(4S,5S)-2,2-Dimethyl-4-[4-(methylsulfonyl)-phenyl]-1,3-dioxan-5-yI]-5H- dibenzo[c,e]azepinium tetraphenylborate: Prepared according to the general procedure from (+)-(4S,5S)-2,2-dimethyl-4-[4- (methylsulfonyl)-phenyl]-1 ,3-dioxan-5-amine (0.30 g, 1.05 mmol). The product was isolated as yellow plates (0.54 g, 66%); m.p. 162-165°C (dec); Found: C, 75.14; H, 5.89; N, 1.75. C51H48BNO4S»2.0H2O requires C, 74.87; H, 6.29; N, 1.71.; m/z 462.1739; C27H28NO4S (cation) requires 462.1739.
(+)-2-[(4S,5S)-2,2-Dimethyl-4-[4-(methyloxy)-phenyl]-1,3-dioxan-5-yl]-5H- dibenzo[c,e]azepinium tetraphenylborate:
Prepared according to the general procedure from (-)-(4R,5R)-2,2-dimethyl-4-[4- (methyloxy)-phenyl]-1 ,3-dioxan-5-amine (0.13 g, 0.48 mmol). The product was isolated as yellow plates (0.23 g, 64%); m.p. 207-209°C (dec); Found: C, 76.58; H, 6.02; N, 1.84. C51H48BNO3«3.5H2O requires C, 76.84; H, 6.52; N, 1.76.; m/z 414.2063; C27H28NO3 (cation) requires 414.2069.
General procedure for the synthesis of 3H-4-azapinium-cyclohepta[2,1-a;3,4- a']dinaphthalene salts from (R) or (S)-2'-Bromomethyl-[1,1']binaphthalenyl-2- carbaldehyde and primary amines:
A solution of the amine in ethanol, (10 ml per g of amine, 1 equivalent), was added dropwise via a stoppered, pressure equalising, dropping funnel, to a one-neck flask, containing a solution of (R) or (S)-2'-Bromomethyl-[1,1']binaphthalenyl-2-carbaldehyde,
(1.10 equiv.) in ethanol (10 ml/g carbaldehyde) warmed at 35°C. After the addition was complete the dropping funnel was removed and replaced by a stopper to contain the hydrogen bromide generated temporarily in the reaction. The reaction mixture was stirred overnight while attaining ambient temperature. Sodium tetraphenylborate, (or any other anion exchanging salt, 1.10 equivalents), in the minimum amount of acetonitrile, was added in one portion to the reaction mixture and after 5 minutes of stirring, the organic solvents are removed under reduced pressure. Ethanol was added to the residue, followed by water. The resulting solid was collected by filtration and washed with additional ethanol followed by hexane. If no solid materialises after the addition of the water the suspension is allowed to settle and the ethanol/water phase is decanted off.
The gummy residue which may be obtained, is macerated in hot ethanol or methanol. The organic salt may then precipitate but in some rare cases it does so upon slow cooling of the hot alcoholic solution. If solubility problems do arise, small amounts of acetonitrile may be added during this process.
(R)-Trifluoro-methanesulfonic acid 2'-trifluoromethanesulfonyloxy [1,1']binaphthalenyl-2-yl ester:
(R)-[1 ,1']Binaphιhalenyl-2,2'-diol (1.70 g, 5.9 mmol) was dissolved in dichloromethane (40 ml) and cooled to -30°C. To this was added 4-dimethylaminopyridine (0.289 g, 2.4 mmol), 2,6-lutidine (2.06 ml, 17.7 mmol) and triflic anhydride (2.98 ml, 17.7 mmol). The solution was allowed to warm to room temperature and stirred for 4 h. Silica gel was added to the solution and the solvent evaporated under reduced pressure. The compound adsorbed on silica was transferred to a fritted glass funnel and washed with ethyl acetate/light petroleum until the title compound had eluted. Solvents were removed under reduced pressure to yield a crude colourless solid, which was recrystallized from hexane to give colourless crystals (3.20 g, 99%), m.p. 68-70°C; [α]20 D -145.3° (c 1.08, CHCI3); vmax(film) /cm"1 3062, 1508, 1424, 1246, 1140, 1065, 963, 865; δH (250 MHz; CDCI3) 7.25 (2H, m), 7.40 (2H, m), 7.59 (4H, m), 8.00 (2H, d, J 8.2 Hz), 8.13 (2H, d, J 9.0 Hz); δc (100 MHz; CDCI3) 118.12, 119.33, 123.46, 126.76, 127.33, 127.99, 128.36, 132.00, 132.37, 133.17,
145.41 ; m/z 549.9974; C22H12F6O6S2 (M+) requires 549.9980.
(S)-Trifluoro-methanesulfonic acid 2"-trifluoromethanesulfonyloxy [1,1']binaphthalenyl-2-yl ester: Prepared in an identical manner to the (R)-enantiomer above, from (S)- [1 ,1']binaphthalenyl-2,2'-diol (6.76 g, 24.0 mmol). Colourless crystals (13.0 g, 99%); m.p. 65-67°C; [α]20 D +140.6 (c 1.09, CHCI3).
(RJ^'-Dimethyl-Il.ribinaphthalenyl : (f?)-Trifluoro~methanesulfonic acid 2'-trifluoromethanesulfonyloxy [1 ,1']binaphthalenyl-2-yl ester (13.0 g, 23.6 mmol) and 1 ,3-bis(diphenylphosphino)propane nickel(ll)chloride (1.10 g, 1.7 mmol) were dissolved in anhydrous diethyl ether (100 ml). The reaction was cooled to -10°C in a ice/salt bath and methylmagnesium bromide (3 M in Et2O, 31.5 ml, 94.4 mmol) was added dropwise over 30 min. The reaction was allowed to attain ambient temperature and stirred over night. The dark green/brown solution was diluted with diethyl ether (150 ml) and filtered through celite (to remove the nickel catalyst). The filtrate was washed with 0.5 M hydrochloric acid (2 x 50 ml) and brine (50 ml). Removal of solvent under reduced pressure yielded a red/orange crude oil, which was purified by column chromatography eluting with hexane to give a pale yellow oil. Crystallization from methanol afforded the product as colourless crystals (6.00 g, 90%); m.p. 68-72°C (Lit 67-
71 °C); [α]20 D -39.0° (c 1.12, CHCI3); vmax(film) /cm"1 3053, 2246, 1594, 1506, 1421 , 1379, 1351 , 1221 , 1143, 1027, 913, 865; δH (250 MHz; CDCI3) 2.03 (6H, s), 7.04 (2H, d, J 8.4Hz), 7.19 (2H, m), 7.35 (2H, m), 7.37 (2H, d, J 8.3 Hz), 7.86 (2H, d, J 8.4 Hz), 7.88 (2H, d, J 8.4 Hz); δc (100 MHz; CDCI3) 20.01 , 124.87, 125.62, 126.06, 127.41 , 127.90, 128.70, 132.20, 132.75, 134.25, 135.11 ; m/z 300.1747; C22H22N (M+NH4) requires
300.1752.
(SJ^^'-Dimethyl-ϊl.rjbinaphthalenyl:
Prepared in an identical manner to the (R)-enantiomer above, from (S)-trifluoro- methanesulfonic acid -trifluoromethanesulfonyloxy [1 ,1']binaphthalenyl-2-yl ester (5.00g, 9.0 mmol). Colourless crystals (2.33 g, 92%); m.p. 71-73°C; [α]20 D +37.0°(c 1.01 , CHCI8).
(R)-2,2'-DibromomethyI-[1,1']binaphthalenyl:
Method 1 :
(R)-2,2'-Dimethyl-[1 ,1']binaphthalenyl (5.00 g, 17.7 mmol) was dissolved in carbon tetrachloride (70 ml) and Λ/-bromosuccinamide (6.63 g, 37.2 mmol), benzoyl peroxide (0.057 g, 0.2 mmol) were added. The mixture was heated under reflux for 24 h and upon cooling the solvent was removed under reduced pressure. The red/brown residue which remained, was diluted with chloroform and washed with water and brine. The organics were dried (MgSO4) and solvent removed under reduced pressure. Recrystallization from chloroform/hexane afforded the product as colourless crystals (3.5 g, 45%). The remaining filtrate was concentrated and subjected to column chromatography eluting with light petroleum/ethyl acetate (97:3). Giving 0.18 g of starting material and a further 1.50 g of product (after recrystallization from chloroform/hexane), a total of 5.0 g, 64%.
Method 2:
(R^^'-DimethyHl .rjbinaphthalenyl (3.00 g, 10.6 mmol), Λ/-bromosuccinamide (3.78 g, 21.3 mmol) and AIBN (10 mol%, 0.174 g, 1.1 mmol) were stirred in carbon tetrachloride (35 ml). The solution was irradiated with visible light (150 Watt Philips tungsten bulb) for 5 h. The reaction mixture was filtered through a fritted glass funnel and a scoop of silica added. The solvent was removed under reduced pressure to give the reaction mixture adsorbed onto silica. Immediately chromatographed eluting with light petroleum/ethyl acetate (97:3) to afford a colourless solid, recrystallized from chloroform/hexane. Colourless crystals (4.10 g, 88%).
Method 3:
Prepared as Method 2, from (R)-2,2'-Dimethyl-[1 ,1']binaphthalenyl (4.00 g, 14.2 mmol), using cyclohexane as reaction solvent (60 ml). Colourless crystals (5.50 g, 88%). m.p. 185-187°C; [α]20 D -164.4° (c 1.04, benzene); vmax(film) /cm"1 3049, 2360, 1506, 1431 , 1210, 818, 749, 684; δH (400 MHz; CDCI3) 4.25 (4H, s), 7.07 (2H, d, J 8.0 Hz), 7.25 (2H, m), 7.46 (2H, m), 7.74 (2H, d, J 8.0 Hz), 7.91 (2H, d, J 8.0 Hz), 8.00 (2 H, d, J 8.0 Hz); δc (100 MHz; CDCI3) 32.61 , 126.78, 126.80, 127.61 , 127.74, 128.02, 129.35, 132.50, 133.25, 134.07, 134.17; m/z 437.9614; C22H16Br2 (M+) requires 437.9619.
(S)-2,2'-Dibromomethyl-[1,1']binaphthalenyl:
Prepared in an identical manner to the (R)-enantiomer above (method 1), from (S)-2,2'- dimethyl-[1 ,1']binaphthalenyl (2.00 g, 7.1 mmol). Colourless crystals (1.87 g, 60%); m.p. 181-183°C; [α]20 D -159.0° (c 1.17, benzene).
(R)-3,5-Dihydro-4-oxa-cyclohepta[2,1-a;3,4-a']dinaphthalene: (R)-2,2'-Dibromomethyl-[1 ,1']binaphthalenyl (0.50 g, 1.1 mmol) was suspended in a mixture of sat. aq. sodium carbonate solution and 1 ,4-dioxane (1 :1 , 60 ml). The solution was heated under reflux for 12 h. Upon cooling the mixture was extracted with diethyl ether (3 x 30 ml), washed with brine (2 x 20 ml) and dried. Removal of the solvent under reduced pressure afforded a yellow oil (TLC visualised using UV shows product as bright blue spot). Column chromatography eluting with ethyl acetate/light petroleum (0:100- 10:90) gave a colourless solid, recrystallized from chloroform/hexane, (0.21 g 65%); m.p. 187-188°C; [α]20 D -551.2° (c 1.12, CHCI3); vmax(film) /cm"1 3052, 2983, 2926, 1594, 1508, 1465, 1420, 1368, 1265, 1158, 1056, 895; δH (250 MHz; CDCI3) 4.18 (2H, d, 11.33 Hz), 4.64 (2H, d, J 11.33 Hz), 7.29 (2H, m), 7.50 (4H, m), 7.61 (2H, d, J 8.33 Hz), 7.97 (4H, dd, J 7.99 Hz); δc (100 MHz; CDCI3) 67.44, 125.85, 125.94, 127.35, 127.59, 128.35, 129.15, 131.16, 133.55, 133.64, 135.46; m/z 296.1205; C22H16O (M+) requires 296.1201.
(S)-3,5-Dihydro-4-oxa-cyclohepta[2,1-a;3,4-a']dinaphthalene:
Prepared in an identical manner to the (R)-enantiomer above, from (S)-2,2'- dibromomethyl-[1 ,1']binaphthalenyl (7.00 g, 15.9 mmol). Colourless crystals (3.10 g, 66%); m.p. 186-188°C; [α]20 D +572.6° (c 1.04, CHCI3).
(R)-2'-Bromomethyl-[1 ,1 ']binaphthalenyl-2-carbaldehyde:
To an ice-cooled solution of (R)-3,5-dihydro-4-oxa-cyclohepta[2,1-a;3,4-a']dinaphthalene (3.0 g, 9.6 mmol) in carbon tetrachloride (50 ml), molecular bromine (1.24 g, 7.8 mmol) as a solution in carbon tetrachloride (5 ml) was added over a period of 5 min (solution turned dark red). After a further 5 min the ice bath was removed and the reaction mixture heated under reflux until it became pale yellow (ca 1 h). The solvent was removed under reduced pressure and the residue obtained dissolved in diethyl ether. The organic solvents were washed with sat. aq. sodium hydrogen carbonate (2 x 50 ml) and brine (2 x 30 ml). The organic solution was dried (MgSO4) and solvents were removed under reduced pressure to yield a orange oil. Crystallization from ethyl acetate afforded the product as colourless crystals (2.33 g, 65%); m.p. 151-153°C; [α]20 D +144.7° (c 1.02, CHCI3); Found: C, 70.04; H, 3.78. C22H15BrO requires C, 70.41 ; H, 4.03.; vmax(film) /cπr1 3058, 1688, 1594, 1430, 1324, 1212, 1027, 821 , 749; δH (250 MHz; CDCI3) 4.07 (1 H, d, J 10.2 Hz), 4.27 (1 H, d, J 10.2 Hz), 7.01 (1 H, dq, J 8.4, 2.0 Hz) 7.22-7.38 (3H, m), 7.50
(1 H, m), 7.63 (1 H, m), 7.72 (1 H, d, J 8.6 Hz), 7.93-8.12 (4H, m), 8.22 (1 H, d, J 8.6 Hz), 9.56 (1 H, d, J 0.9 Hz); δc (100 MHz; CDCI3) 31.92, 122.38, 126.56, 126.94, 127.03, 127.39, 127.40, 128.17, 128.48, 129.20, 129.34, 129.85, 132.41 , 132.42, 132.53, 132.97, 133.56, 134.63, 136.29, 141.59, 191.81 ; m/z 374.0310; C22H15BrO (M+) requires 374.0306.
(S)-2"-Bromomethyl-[1 ,1 ']binaphthalenyl-2-carbaldehyde:
Prepared in an identical manner to the (R)-enantiomer above, from (S)-3,5-dihydro-4-oxa- cyclohepta[2,1-a;3,4-a']dinaphthalene (2.30 g, 7.8 mmol). Colourless crystals (1.87 g, 64%); m.p. 154-155°C; [α]20 D -140.3° (c 1.13, CHCI3).
(R)-[(4S,5S)-2,2-dimethyI-4-phenyl-1,3-dioxan-5-yl]-3H-4-azapinium-cycIohepta[2,1- a;3,4-a']dinaphthalene tetraphenylborate: Prepared according to the general procedure from (+)-(4S,5S)-2,2-Dimethyl-4-phenyl-1 ,3- dioxan-5-amine (0.15 g, 0.72 mmol). The product was isolated as yellow plates (0.39 g, 66%); m.p. 111-113°C (dec); [α]20 D -98.5° (c 1.04, acetone); Found: C, 84.44; H, 5.97; N, 1.71. C58H50BNO2«1.0H2O requires C, 84.73; H, 6.13; N, 1.71.; vmax(film) /cm"1 3055, 2986, 1626, 1610, 1593, 1548, 1478, 1450, 1382, 1266, 1203, 1110, 846, 817, 735, 704; δH(400 MHz; acetone-d6) 1.79 (3H, s), 1.85 (3H, s), 4.43 (1 H, d, J 13.2 Hz), 4.51 (1H, d, J 13.6
Hz), 4.86 (2H, m), 5.98 (2H, m), 6.76 (4H, t, J 7.2 Hz), 6.93 (8H, t, J 7.6 Hz), 6.95-7.10 (5H, m), 7.18-7.32 (2H, m), 7.34 (8H, m), 7.45 (3H, m), 7.45-7.65 (2H, m), 7.78 (1 H, m), 7.88 (1 H, d, J 8.4 Hz), 8.10 (1 H, d, J 8.4 Hz), 8.17 (1 H, d, J 8.4 Hz), 8.23 (1 H, dd, J 8.4, 2.4 Hz), 9.29 (1 H, s); δH(400 MHz; acetone-d6) 19.34, 29.69, 57.00, 62.26, 68.42, 72.94, 102.06, 120.51 , 122.67, 126.33, 126.40, 126.58, 127.30, 128.11 , 128.15, 128.38, 129.05,
129.19, 129.88, 130.04, 130.12, 130.57, 130.65, 131.70, 132.16, 132.57, 132.92, 133.25, 135.25, 136.61 , 137.43, 142.75, 165.25, 171.37; m/z 484.2275; C34H30NO2 (cation) requires 484.2277.
(S)-[(4R,5R)-2,2-dimethyl-4-phenyl-1 ,3-dioxan-5-yl]-3H-4-azapinium-cyclohepta[2,1 - a;3,4-a']dinaphthalene tetraphenylborate:
Prepared according to the general procedure from (-)-(4R,5R)-2,2-Dimethyl-4-phenyl-1 ,3- dioxan-5-amine (0.16 g, 0.77 mmol). The product was isolated as yellow plates (0.40 g, 64%), having almost identical spectroscopic data to its enantiomer above: m.p. 109- 112°C (dec); [α]20 D +95.3° (c 1.01 , acetone).
(S)-[(4S,5S)-2,2-dimethyl-4-phenyl-1,3-dioxan-5-yl]-3H-4-azapinium-cyclohepta[2,1- a;3,4-a']dinaphthalene tetraphenylborate:
Prepared according to the general procedure from (+)-(4S,5S)-2,2-Dimethyl-4-phenyl-1 ,3- dioxan-5-amine (0.20 g, 0.97 mmol). The product was isolated as yellow plates (0.50 g, 64%); m.p. 218°C (dec); Found: C, 84.33; H, 6.06; N, 1.64. C58H50BNO2«1.0H2O requires C, 84.73; H, 6.13; N, 1.71.; m/z 484.2282; C34H30NO2 (cation) requires 484.2277.
H-(R)-6-[(1R,2R>3R,5S)-2,6J6-trimethylbicyclo[3.1.1]hept-3-yl]- 3H-4-azapinium-cyclohepta[2,1-a;3,4-a']dinaphthalene tetraphenylborate:
Prepared according to the general procedure from (-)-isopinocampheylamine (0.25 g, 1.6 mmol). The product was isolated as yellow plates (0.82 g, 73%), mp 219-221 °C (dec); Found: C, 88.22; H, 6.81 ; N, 1.79%. C48H48BN«0.5H2O requires C, 88.61 ; H, 6.91 ; N, 1.85%.; m/z 430.2540; C32H32N (cation) requires 430.2535.
(+)-(S)-6-[(1R,2R,3R,5S)-2,6,6-trimethylbicyclo[3.1.1]hept-3-yl]- 3H-4-azapinium-cyclohepta[2,1-a;3,4-a']dinaphthalene tetraphenylborate:
Prepared according to the general procedure from (-)-isopinocampheylamine (0.25 g, 1.6 mmol). The product was isolated as yellow plates (0.82 g, 73%), mp 225-227°C (dec); Found: C, 88.38; H, 6.86; N, 1.80%. C48H48BN«0.5H2O requires C, 88.61 ; H, 6.91 ; N, 1.85%.; m/z 430.2536; C32H32N (cation) requires 430.2535.
General procedure for catalytic asymmetric epoxidation of simple alkenes mediated by iminium salts using Tetraphenylphosphonium monoperoxysulfate:
Tetraphenylphosphonium monoperoxysulfate (2 eq with respect to the substrate) was dissolved in the desired solvent (2 ml per 0.1 g oxidant) and cooled to the required temperature. To this was added the iminium salt as a solution in the solvent (0.5 ml per 0.1 g oxidant). This iminium salt solution was cooled to the same temperature as the solution containing the oxidant and added dropwise over 15-20 min, the temperature of the reaction vessel was monitored to minimize increase in temperature during the addition. The substrate (100 mol%) was also added as a solution in the reaction solvent (0.5 ml per 0.1 g oxidant) in the same manner as the catalyst. The reaction was stirred at the same temperature until the substrate was completely consumed by TLC. Diethyl ether (pre-cooled to the reaction temperature) (20 ml per 0.1 g oxidant) was then added to precipitate the remaining oxidant. The solution was then filtered through Celite. Solvents are removed. Diethyl ether (40 ml) was then added to the brown residue obtained and the solution passed through a short pad of silica (to remove catalyst residues). Solvent was again removed to yield the pure epoxide. If the reaction did not go to completion the epoxide can be separated from the alkene through the use of column chromatography eluting with ethyl acetate/light petroleum 1 :99.
Tetraphenylphosphonium monoperoxysulfate: Ph4P+ cr + Oxone™(2 KHSO5:KHSO4: K2SO4) → Ph4P+(HSO5)-
Oxone™ triple salt (2 KHSO5:KHSO4:K2SO4) (15.0 g, 48.8 mmol, w.r.t. KHSO5) was dissolved in deionised water (300 ml) in a conical flask (1 L) and kept under magnetic stirring at 10-15°C (water bath). To this solution tetraphenylphosphonium chloride (15.0 g, 40.0mmol) in distilled dichloromethane (300 ml) was gradually added over 5 min. After an additional 30 min, stirring was interrupted, the organic layer was separated and solvent was removed under vacuum at room temperature. The crude white salt was then transferred to a fritted glass funnel and washed with distilled water (2 x 75 ml). The solid was dissolved in dichloromethane (180 ml), dried (MgSO4) and hexane was added until cloudiness develops and the flask was placed in the freezer (-20°C) overnight, producing a solid white precipitate. Ca 85% pure in peroxide, yield 15.4 g, 70%. δH (250 MHz; CDCI3) 7.64 (8 H, m, 8 x CH arom.), 7.78 (8 H, m, 8 x CH arom.), 7.89 (4 H, m, 4 x CH arom., para to P), 8.92 (1 H, s, OH).
EPOXIDATIONS USING TPPP AND ORGANIC SOLVENT CONDITIONS:
(-)-3S,4S-2,2-Dimethyl-1a,7b-dihydro-2H-1,3-dioxa-cyclopropa[a]naphthalene-6- carbonitrile : Tetraphenylphosphonium monoperoxysulfate (2 eq, 4.90 g, 10.8 mmol) was dissolved in chloroform (98 ml) and cooled to -40°C. To this was added the iminium salt, (+)-[(4S,5S)- 2,2-dimethyl-4-[4-(methylsulfonyl)-phenyl]-1 ,3-dioxan-5-yl]-3,4-dihydroisoquinolinium tetraphenylborate, (0.39g, 0.54 mmol) as a solution in chloroform (24.5 ml). This iminium salt solution was cooled to the same temperature as the solution containing the oxidant and added dropwise over 15-20 min, the temperature of the reaction vessel was monitored to minimize increase in temperature during the addition. The substrate (1.0 g, 5.4 mmol) was also added as a solution in chloroform (24.5 ml) in the same manner as the catalyst. The reaction was stirred at 40°C for 24 h. Diethyl ether (pre-cooled to -40 °C) was then added to precipitate the remaining oxidant. The solution was filtered through Celite. Solvents were removed under reduced pressure to afford a pale yellow oil. Column chromatography eluting with ethyl acetate/light petroleum 1 :99 gave the product as a colourless oil which solidified (0.64 g, 59% yield, 97% ee): [α]20 D -59.5° (c 1.09, CHCI3), [lit +62.7° (c 0.71 , CHCI3) for (+)-3R,4R enantiomer]; vmax(film)/crrr1 3089, 3038, 2979, 2934, 2226, 1615, 1579, 1490, 1346, 1279, 1157, 1107, 1046, 955; δH(400 MHz; CDCI3) 1 -22 (3 H, s, CH3, C11), 1.52 (3H, s), 3.47 (1 H, d, J 4.4 Hz), 3.86 (1 H, d, J
4.4 Hz), 6.79 (1 H, d, J 8.4 Hz), 7.45 (1 H, dd, J 2.0, 8.4 Hz), 7.58 (1 H, d, J 2.4 Hz); δc(100 MHz; CDCI3) 23.41 , 25.88, 50.26, 62.69, 75.07, 104.65, 118.97, 119.15, 121.51, 134.21, 134.80, 156.87; m/z 219.1132; C^H^NO, (M+NH4) requires 219.1134.
Cis-β-methylstyrene oxide:
Tetraphenylphosphonium monoperoxysulfate (2 eq, 0.768 g, 1.70 mmol) was dissolved in chloroform (16 ml) and cooled to -40°C. To this was added the iminium salt, (+)-[(4S,5S)- 2,2-dimethyl-4-[4-(methylsulfonyl)-phenyl]-1 ,3-dioxan-5-yl]-3,4-dihydroisoquinolinium tetraphenylborate, (10 ol %, 0.061 g, 0.09 mmol) as a solution in chloroform (4 ml). This iminium salt solution was cooled to the same temperature as the solution containing the oxidant and added dropwise over 15-20 min, the temperature of the reaction vessel was monitored to minimize increase in temperature during the addition. The substrate (0.10 g, 0.85 mmol) was also added as a solution in chloroform (4 ml) in the same manner as the catalyst. The reaction was stirred at -40°C for 24 h. Diethyl ether (20 ml) (pre-cooled to -40°C) was then added to precipitate the remaining oxidant. The solution was filtered through Celite. Solvents were removed under reduced pressure to afford a pale yellow oil. Column chromatography eluting with ethyl acetate/light petroleum 1 :99 gave the product as a colourless oil (0.97 g, 85% yield, 70% ee, (+)-1S,2R). vmax(neat)/cm'1 3061 , 2994, 1604, 1496, 1450, 1258, 1149, 9563, 853, 742, 700, 619; δH(250 MHz; CDCI3) 1.12, (3H, d, J 5.4 Hz), 3.32-3.40 (1 H, m), 4.08 (1 H, d, J 4.3 Hz), 7.24-7.39 (5H, m); δc(62.5 MHz; CDCI3) 12.84, 55.37, 57.78, 126.85, 127.74, 128.26, 135.84.
Epoxidation of simple tri-substituted alkenes using (R)-[(4S,5S)-2,2-dimethyl-4- phenyl-1,3-dioxan-5-yl]-3H-4-azapinium-cycIohepta[2,1-a;3,4-a']dinaphthalene tetraphenylborate3:
Figure imgf000025_0001
a Epoxidation conditions: Iminium salt (10 mol %), Tetraphenylphosphonium monoperoxysulfate (2 eq), MeCN, -40 C.
" Isolated yield. c Enantiomeric excess determined by 1H-NMR with (+)-Eu(hfc)3 (0.1 mol eq) as chiral shift reagent. d The absolute configuration of the major enantiomer was determined by comparison to those reported in the literature. e Numbers in brackets refer to the corresponding reaction carried out in chloroform. EPOXIDATIONS USING SPECIFIC CATALYSTS UNDER OXONE / WATER CONDITIONS:
General procedure for catalytic asymmetric epoxidation of simple alkenes mediated by iminium salts using Oxone:
To an ice cooled solution of sodium carbonate, (4 equivalents), in water (12 ml per 1.50 g of sodium carbonate), Oxone™ (2 equivalents), was added with stirring and the resulting foaming solution was left to stir for 5-10 minutes, so that most of the initial effervescence subsides. The iminium salt, (10 mol% with respect to the substrate), was then added as a solution in acetonitrile, (6 ml per 1.50 g of sodium carbonate used), followed by the alkene substrate, (1 equivalent, 100 mol%), also as a solution in acetonitrile of the same volume as the solution of the catalyst. The suspension was stirred at the same temperature until the substrate was completely consumed by TLC. The reaction mixture was then diluted with ice cooled diethyl ether (20 ml per 100 mg substrate) and was immediately followed by the addition of the same volume of water. The aqueous phase was washed 4 times with diethyl ether and the organics are combined, washed with brine and dried. Filtration and evapouration of the solvents furnishes a yellow or light brown residue. Column chromatography was then performed typically using ethyl acetate : Light petroleum 1 :99 to produce the pure epoxide.
Study of Catalyst loading on the epoxidation of 1-phenylcyclohexenea
To an ice cooled solution of sodium carbonate (0.26 g, 2.52 mmol), in water (2.1 ml), Oxone™ (0.77 g, 1.26 mmol), was added with stirring and the resulting foaming solution was left to stir for 5-10 minutes, so that most of the initial effervescence subsided. The iminium salt, (0.5 mol %, 0.0025g, 0.0032 mmol), was then added as a solution in acetonitrile, (1.05 ml), followed by the alkene substrate, (1 equivalent, 0.10 g, 0.63 mmol), also as a solution in acetonitrile (1.05 ml). The suspension was stirred at the same temperature until the substrate was completely consumed by TLC (2.0 h). The reaction mixture was then diluted with ice cooled diethyl ether (20 ml) and immediately followed by the addition of water (20 ml). The aqueous phase was washed with diethyl ether (4 x 20 ml) and the organics were combined, washed with brine and dried (MgSO4). Filtration and evaporation of the solvents furnished a light brown residue. Column chromatography eluting with ethyl acetate : light petroleum (1 :99) afforded the pure epoxide as a colourless oil (0.071 g, 65 %, 91 % ee, (-)-1S,2S). Colourless oil; vmax(neat)/cm"1 3084, 1602, 1495, 1446, 1359, 1249, 1173, 1132, 1079, 1030, 993, 974; δH(250 MHz; CDCI3) 1.22-1.35 (1 H, m), 1.53-1.64 (3H m), 1.99-2.06 (2H, m) 2.16-2.18 (1 H, m), 2.26-2.32 (1 H, m), 3.10 (1 H, t, J 2.0 Hz), 7.28-7.44 (5 H, m); δc (62.5 MHz; CDCI3) 19.8, 20.1 , 24.7, 28.2, 60.1 , 61.8, 125.3, 127.1 , 128.2, 142.8. The experiment was repeated with varying levels of catalyst.
Figure imgf000027_0001
a Conditions: Cat = (R)-[(4S,5S)-2,2-dimethyl-4-phenyl-1,3-dioxan-5-yl]-3H-4-azapinium- cyclohepta[2,1-a;3,4-a']dinaphthalene tetraphenylborate, Oxone (2 eq), Na2CO3 (4 eq),
MeCN/H2O (1:1), 0 °C. b Isolated yields.
0 Enantiomeric excesses were determined by 1H NMR spectroscopy in the presence of
(+)-Eu(hfc)3 (0.1 mol eq). d The absolute configurations of the major enantiomers were determined by comparison of the optical rotation with those reported in the literature.
Comparison of literature methods for the asymmetric epoxidation of 1- phenylcyclohexene
Figure imgf000028_0001
Ref 1. Aggarwal, V. K.; Wang, M. F. J. Chem. Soc, Chem. Commun., 1996, 191. Ref 2. Bohe, L.; Lusinchi, M.; Lusinchi, X. Tetrahedron, 1999, 55, 141. Ref 3. Wong, M-K.; Ho, L-M.; Zheng, Y-S.; Ho, C-Y.; Yang, D. Org. Lett., 2001 , 16, 2587. Ref 4. Page, P. C. B.; Rassias, G. A.; Barros, D.; Ardakani, A.; Buckley, B.; Bethell, D.; Smith, T. A. D.; Slawin, A. M. Z. J. Org. Chem. 2001 , 66, 6926. Ref 5. Page, P. C. B.; Rassias, G. A.; Barros, D.; Ardakani, A.; Bethell, D.; Merifield, E. Synlett, 2002, 4, 580.
Conclusion: Catalyst of the present invention is highly effective, resulting in higher ee's. High ee's are achievable even at very low loading of catalyst.
Asymmetric epoxidation of alkenes mediated by an iminium salt catalyst a 1-Phenyl-3,4-dihydronaphthalene oxide: To an ice cooled solution of sodium carbonate (0.20 g, 1.96 mmol), in water (1.6 ml), Oxone™ (0.60 g, 0.98 mmol), was added with stirring and the resulting foaming solution was left to stir for 5-10 minutes, so that most of the initial effervescence subsided. The iminium salt, (5 mol %, 0.020 g, 0.025 mmol), was then added as a solution in acetonitrile, (0.8 ml), followed by the alkene substrate, (1 equivalent, 0.10 g, 0.49 mmol), also as a solution in acetonitrile (0.8 ml). The suspension was stirred at the same temperature until the substrate was completely consumed by TLC (0.35 h). The reaction mixture was then diluted with ice cooled diethyl ether (20 ml) and immediately followed by the addition of water (20 ml). The aqueous phase was washed with diethyl ether (4 x 20 ml) and the organics were combined, washed with brine and dried (MgSO4). Filtration and evaporation of the solvents furnished a light brown residue. Column chromatography eluting with ethyl acetate : light petroleum (1 :99) afforded the pure epoxide as a colourless oil which solidified (0.072 g, 66 %, 95 % ee, (-)-1 S,2R). mp 104-106 °C; vmax(nujol)/cm"1 1602, 1486, 1307, 1155, 1074, 1042, 953; δH(250 MHz; CDCI3) 2.10 (1 H, td, J 5.8 and 13.7 Hz), 2.49-2.60 (1 H, m), 2.77 (1 H, dd, J 5.6 and 15.5 Hz), 2.98-3.06 (1 H, m), 3.71 (1 H, d, 3.1 Hz), 7.11-7.31 (4H, m), 7.45-7.61 (5H, m); δc(62.5 MHz; CDCI3) 22.1 , 25.4, 60.9, 63.0, 126.0, 127.7, 127.9, 128.1 , 128.2, 128.6, 129.8, 135.0, 137.5, 138.8.
Figure imgf000029_0001
a Conditions: (R)-[(4S,5S)-2,2-dimethyl-4-phenyl-1 ,3-dioxan-5-yl]-3H-4-azapinium- cyclohepta[2,1-a;3,4-a']dinaphthalene tetraphenylborate (5 mol%), oxone (2 eq), Na2CO3 (4 eq), MeCN/H2O (1 :1 ), 0 °C. b Isolated yields. c Enantiomeric excesses were determined by 1H NMR spectroscopy in the presence of (+)-Eu(hfc)3 (0.1 mol eq) or by chiral HPLC using a Chiracel OD column. d The absolute configurations of the major enantiomers were determined by comparison of the optical rotation with those reported in the literature.
Conclusion: Catalyst shows good ee even with terminal olefins
Comparison of the Oxone/MeCN-H2O and TPPP reaction conditions: 1, 2-Dihydronapthylene oxide - Oxone/Water:
To an ice cooled solution of sodium carbonate (0.32 g, 3.08 mmol), in water (2.6 ml), Oxone™ (0.95 g, 1.54 mmol), was added with stirring and the resulting foaming solution was left to stir for 5-10 minutes, so that most of the initial effervescence subsided. The iminium salt, (10 mol %, 0.055 g, 0.08 mmol), was then added as a solution in acetonitrile, (1.3 ml), followed by the alkene substrate, (1 equivalent, 0.10 g, 0.77 mmol), also as a solution in acetonitrile (1.3 ml). The suspension was stirred at the same temperature until the substrate was completely consumed by TLC (2.0 h). The reaction mixture was then diluted with ice cooled diethyl ether (20 ml) and immediately followed by the addition of water (20 ml). The aqueous phase was washed with diethyl ether (4 x 20 ml) and the organics were combined, washed with brine and dried (MgSO4). Filtration and evaporation of the solvents furnished a light brown residue. Column chromatography eluting with ethyl acetate : light petroleum (1 :99) afforded the pure epoxide as a colourless oil (61 % conversion, 45 % ee, (-)-1S,2R). vmax(neat)/cm"1 3059, 3028, 2930, 2850, 1602, 1493, 1316, 1129, 1088, 1030, 964; δH(400 MHz; CDCI3) 1.67 (1 H, m), 2.33 (1 H, m), 2.45 (1 H, dd, J 15.6, 5.6 Hz), 2.67 (1 H, m), 3.65 (1 H, t, J 4.0 Hz), 3.78 (1 H, d, J 4.4 Hz), 7.01 (1 H, d, J 7.2 Hz), 7.17 (2H, m), 7.33 (1 H, d, J 7.2 Hz); δc(100 MHz; CDCI3) 22.19, 24.78, 55.16, 55.52, 126.51 , 128.80, 128.83, 129.94, 132.91 , 137.07.
1 ,2-Dihydronapthylene oxide - Tetraphenylphosphonium monoperoxysulfate/Organic
Solvent :
Tetraphenylphosphonium monoperoxysulfate (2 eq, 0.696 g, 1.54 mmol) was dissolved in chloroform (14 ml) and cooled to -40°C. To this was added the iminium salt (10 mol %,
0.055 g, 0.08 mmol) as a solution in chloroform (3.5 ml). This iminium salt solution was cooled to the same temperature as the solution containing the oxidant and added dropwise over 15-20 min, the temperature of the reaction vessel was monitored to minimize increase in temperature during the addition. The substrate (0.10 g, 0.77 mmol) was also added as a solution in chloroform (3.5 ml) in the same manner as the catalyst. The reaction was stirred at -40°C for 17 h. Diethyl ether (20 ml) (pre-cooled to -40°C) was then added to precipitate the remaining oxidant. The solution was filtered through Celite. Solvents were removed under reduced pressure to afford a pale yellow oil. Column chromatography eluting with ethyl acetate/light petroleum 1 :99 gave the product as a colourless oil (0.10 g, 89% yield, 82% ee, (-)-1 S,2R).
The following alkenes were compared according to the above conditions.
Figure imgf000031_0001
a Conditions: (+)-[(4S,5S)-2,2-dimethyl-4-[4-(methylsulfonyl)-phenyl]-1 ,3-dioxan-5-yl]-3,4- dihydroisoquinolinium tetraphenylborate (10 mol%), oxone (2 eq), Na2CO3 (4 eq), MeCN/H2O (1 :1 ), 0°C. b Conditions: (+)-[(4S,5S)-2,2-dimethyl-4-[4-(methylsulfonyl)-phenyl]-1 ,3-dioxan-5-yl]-3,4- dihydroisoquinolinium tetraphenylborate (10 mol%), TPPP (2 eq), CHCI3, -40°C. c Conversion evaluated from the 1H-NMR by integration of alkene versus epoxide. d Enantiomeric excesses were determined by 1H NMR spectroscopy in the presence of (+)-Eu(hfc)3 (0.1 mol eq) or by chiral HPLC using a Chiracel OD column. e The absolute configurations of the major enantiomers were determined by comparison of the optical rotation with those reported in the literature. f Isolated yields. Stereospecificity under the TPPP conditions: Effect of reaction solvent: Catalytic asymmetric epoxidation of various alkenes using TPPP and (+)-[(4S,5S)-2,2- dimethyl-4-[4-(methylsulfonyl)-phenyl]-1 ,3-dioxan-5-yl]-3,4-dihydroisoquinolinium tetraphenylborate3
Figure imgf000032_0001
a Conditions: (+)-[(4S,5S)-2,2-dimethyl-4-[4-(methylsulfonyl)-phenyl]-1 ,3-dioxan-5-yl]-3,4- dihydroisoquinolinium tetraphenylborate (10 mol %), TPPP (2 eq), Solvent, -40 C, 24 h.
" Isolated yield.
0 Enantiomeric excess determined by H-NMR with (+)-Eu(hfc)3 (0.1 mol eq) as chiral shift reagent or by Chiral HPLC on a Chiracel OD column. d The absolute configuration of the major enantiomer was determined by comparison of the optical rotation with those reported in the literature. e Conversion evaluated from the 1H-NMR by integration alkene versus epoxide.

Claims

1. A process for the preparation of oxiranes wherein an optionally substituted alkene is reacted in the presence of a chiral catalyst, an oxidant and an organic solvent characterised in that the oxidant is at least partially soluble in the organic solvent and the oxidant displays low reactivity towards the alkene in the absence of the catalyst.
2. A process according to Claim 1 wherein the oxidant is a compound of formula (2): A+ HSO5- (2)
wherein A+ is a counterion capable of conferring organic solvent solubility.
3. A process according to Claim 2 wherein the counterions A+ is (PR6R7R8R9)+ wherein R6"9 are optionally substituted aryl groups.
4. A process according to Claim 2 or 3 wherein the oxidants are compounds of formula (3):
Figure imgf000033_0001
(3) wherein: R10 is hydrogen, a polyfluorinated alkyl, a resin or a linker bound to a resin.
5. A process according to Claim 4 wherein R10 is hydrogen.
6. A process according to any one of Claims 1 to 5 wherein the chiral catalyst is a chiral iminium salt of formula (4):
Figure imgf000034_0001
wherein: R11 and R12 are each independently an optionally substituted hydrocarbyl group or R11 & R12 are linked in such a way as to form an optionally substituted ring(s); R13 is hydrogen or an optionally substituted hydrocarbyl group; R14 is an optionally substituted hydrocarbyl group; R17 is hydrogen or an optionally substituted hydrocarbyl group; R15 and R16 each independently are hydrogen or an optionally substituted hydrocarbyl group; and X" is a counterion; * is a chiral centre; and *' is a chiral centre when R17 is not hydrogen.
7. A process according to Claim 6 wherein the catalyst is a compound of formula (4a), (4b), (4c) or (4d):
Figure imgf000034_0002
wherein: R14 is an optionally substituted aryl group; R15 is hydrogen or C1-4 alkyl group; R16 is hydrogen or C1-4 alkyl group; R18 and R19 are each independently hydrogen or a C,^ alkyl group; R20 is preferably an electron donating group; and X" is a counterion.
A process according to Claim 7 wherein the catalyst is a compound of formula (4a), (4b), (4c) or (4d) wherein R14 is an optionally substituted phenyl group; R 5 is hydrogen or a methyl group; R16 is hydrogen or a methyl group; R18 and R19 are each independently hydrogen or a methyl group; R20 is a dihydrocarbylamino group; and X is [BFJ-, [CF3SO3]-, [BPhJ", [PF6]- or [CIO4]\
9. A process according to Claim 8 wherein the catalyst is a compound of formula (4a), (4b), (4c) or (4d) wherein R14 is an optionally substituted phenyl group; R15 is a methyl group; R16 is a methyl group; R18 and R19 are methyl groups; R20 is a dihydrocarbylamino group; and X is [BPh4]', [PFJ- or [CIO4]\
10. A process according to any one of Claims 7, 8 or 9 wherein the catalyst is a compound of formula (4a) wherein R14 is a phenyl group; R15 is a methyl group; and R16 is a methyl group; or the catalyst is a compound of formula (4c) wherein R14 is a C6H4SO2Me group; R15 is a methyl group; and R16 is a methyl group.
11. A process according to any proceeding claim wherein the optionally substituted alkene is compound of formula (1):
Figure imgf000035_0001
(1) wherein: R1"4 each independently are hydrogen, an optionally substituted aromatic or saturated hydrocarbyl, an optionally substituted hetrocyclyl, an optionally substituted aromatic or saturated hydrocarbyloxy, an optionally substituted aromatic or saturated hydrocarbylamino, an optionally substituted aromatic or saturated hydrocarbyloxycarbonyl, an optionally substituted aromatic or saturated hydrocarbylaminocarbonyl, nitrile, halide or one or more of R1&R2, R2&R3, R3&R4, R1&R4 optionally being linked in such a way as to form an optionally substituted ring(s).
12. A catalyst of formula (4a), (4b), (4c) or (4d):
Figure imgf000036_0001
(4a) (4b) (4c) (4d)
wherein: R14 is an optionally substituted aryl group; R15 is hydrogen or C1-4 alkyl group; R16 is hydrogen or C1-4 alkyl group; R18 and R19 are each independently hydrogen or a C1-4 alkyl group; R20 is preferably an electron donating group; and X" is a counterion.
13. A catalyst according to Claim 12 wherein R14 is an optionally substituted phenyl group; R15 is hydrogen or a methyl group; R16 is hydrogen or a methyl group; R18 and R19 are each independently hydrogen or a methyl group; R20 is a dihydrocarbylamino group; and X is [BF4]-, [CF3SO3]-, [BPh4]", [PF6]" or [CIO4]".
14. A catalyst according to Claim 13 wherein R14 is an optionally substituted phenyl group; R15 is a methyl group; R16 is a methyl group; R18 and R19 are methyl groups; R20 is a dihydrocarbylamino group; and X is [BPh4]", [PF6]- or [CIO4]".
15. A catalyst according to any one of Claims 12, 13 or 14 wherein the catalyst is a compound of formula (4a) wherein R14 is a phenyl group; R15 is a methyl group; and R16 is a methyl group, or the catalyst is a compound of formula (4c) wherein R14 is a C6H4SO2Me group; R15 is a methyl group; and R16 is a methyl group.
PCT/GB2004/004936 2003-12-05 2004-11-22 Process for use in the preparation of oxiranes from alkenes, and catalysts for use therein WO2005056543A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0328237A GB0328237D0 (en) 2003-12-05 2003-12-05 Process
GB0328237.3 2003-12-05

Publications (2)

Publication Number Publication Date
WO2005056543A2 true WO2005056543A2 (en) 2005-06-23
WO2005056543A3 WO2005056543A3 (en) 2005-10-06

Family

ID=29764648

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB2004/004936 WO2005056543A2 (en) 2003-12-05 2004-11-22 Process for use in the preparation of oxiranes from alkenes, and catalysts for use therein

Country Status (2)

Country Link
GB (1) GB0328237D0 (en)
WO (1) WO2005056543A2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007013697A1 (en) * 2005-07-29 2007-02-01 Nagase & Co., Ltd. AXIS-ASYMMETRIC OPTICALLY ACTIVE QUATERNARY AMMONIUM SALT, AND PROCESS FOR PRODUCTION OF α-AMINO ACID OR DERIVATIVE THEREOF USING THE QUATERNARY AMMONIUM SALT

Non-Patent Citations (8)

* Cited by examiner, † Cited by third party
Title
ARMSTRONG A ET AL: "Exocyclic Iminium Salts as Catalysts for Alkene Epoxidation by Oxone<(>R)" TETRAHEDRON, ELSEVIER SCIENCE PUBLISHERS, AMSTERDAM, NL, vol. 55, no. 8, 19 February 1999 (1999-02-19), pages 2341-2352, XP004157357 ISSN: 0040-4020 *
ARMSTRONG A ET AL: "Pyrrolidine-derived iminium salts as catalysts for alkene epoxidation by Oxone (R)" September 1997 (1997-09), SYNLETT, THIEME VERLAG, STUTTGART, DE, PAGE(S) 1075-1076 , XP002135878 ISSN: 0936-5214 page 1076; tables 1,2 the whole document *
LACOUR J ET AL: "Effect of the medium on the oxaziridinium-catalyzed enantioselective epoxidation" 11 November 2002 (2002-11-11), TETRAHEDRON LETTERS, ELSEVIER SCIENCE PUBLISHERS, AMSTERDAM, NL, PAGE(S) 8257-8260 , XP004388421 ISSN: 0040-4039 page 8257; figures 1,2; tables 1,2 the whole document *
MAN-KIN WONG ET AL.: "Asymmetric Epoxidation of Olefins catalyzed by Chiral Iminium Salts Generated in Situ from Amines and Aldehydes" ORGANIC LETTERS, vol. 3, no. 16, 18 July 2001 (2001-07-18), pages 2587-2590, XP002334722 USAMERICAN CHEMICAL SOCIETY *
PEKKA PIETIK[INEN: "Asymmetric Epoxidation of Unfunctionalized Alkenes with Ammonium and Phosphonium Monopersulfates Catalysed by Chiral Mn(III)-Salen complexes" TETRAHEDRON., vol. 56, no. 3, 14 January 2000 (2000-01-14), pages 417-424, XP002334725 NLELSEVIER SCIENCE PUBLISHERS, AMSTERDAM. *
PHILIP C. BULMAN PAGE ET AL.: "New Organocatalysts for the Asymmetric Catalytic Epoxidation of Alkenes Mediated by Chiral Iminium salts" SYNLETT., no. 4, 29 March 2002 (2002-03-29), pages 580-582, XP002334721 DETHIEME VERLAG, STUTTGART. *
PHILIP C. BULMAN PAGE ET AL.: "Dihydroisoquinolinium Salts: Catalysts for asymmetric epoxidation" JOURNAL OF THE CHEMICAL SOCIETY, PERKIN TRANSACTIONS 1., 11 September 2000 (2000-09-11), pages 3325-3334, XP002334724 GBCHEMICAL SOCIETY. LETCHWORTH. *
PHILIP C. BULMAN PAGE ET AL.: "Functionalized Iminium salt Systems for catalytic Asymmetric Epoxidation" JOURNAL OF ORGANIC CHEMISTRY., vol. 66, no. 21, 14 September 2001 (2001-09-14), pages 6926-6931, XP002334723 USAMERICAN CHEMICAL SOCIETY, WASHINGTON, DC. *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007013697A1 (en) * 2005-07-29 2007-02-01 Nagase & Co., Ltd. AXIS-ASYMMETRIC OPTICALLY ACTIVE QUATERNARY AMMONIUM SALT, AND PROCESS FOR PRODUCTION OF α-AMINO ACID OR DERIVATIVE THEREOF USING THE QUATERNARY AMMONIUM SALT

Also Published As

Publication number Publication date
GB0328237D0 (en) 2004-01-07
WO2005056543A3 (en) 2005-10-06

Similar Documents

Publication Publication Date Title
Bravo et al. New fluorinated chiral synthons
DK173703B1 (en) Methods for preparing D, L- (threo) and D- (threo) -1-aryl-2-acylamido-3-fluoro-1-propanols, respectively
EA020088B1 (en) Process for preparing bisfuran alcohol derivatives, compounds, salt, pharmaceutical composition based thereon, method for treatment or prophylaxis of retrovirus infections using same
JP6434678B2 (en) Process for producing 7H-pyrrolo [2,3-d] pyrimidine derivative and synthetic intermediate thereof
KR20040073463A (en) Method for the preparation of escitalopram
HUT68255A (en) Process for the preparation of beta-phenylisoserine derivatives and use thereof
EP2914582A2 (en) Chiral fluorinating reagents
KR100261361B1 (en) Process of optically active 2-halo-1-(substituted phenyl)ethanol and optically active substituted styrene oxide, and method of promoting the optical purity of production of optically active 2-halo-1-(substituted phenyl)ethanol produced by the process
Page et al. Asymmetric organocatalysis of epoxidation by iminium salts under non-aqueous conditions
Page et al. Non-aqueous iminium salt mediated catalytic asymmetric epoxidation
WO2005056543A2 (en) Process for use in the preparation of oxiranes from alkenes, and catalysts for use therein
Bredikhina et al. Cyclic sulfites, key intermediates in synthesis of 1-alkylamino-3-aryloxy-2-propanols from glycidol
EA002277B1 (en) Process for alkylating hindered sulphonamides
WO2016199688A1 (en) Method for producing carbamate compound
KR100514819B1 (en) Process for producing chiral glycidyl derivatives
JPWO2004002973A1 (en) Process for producing optically active 1-substituted amino-2,3-epoxypropane, synthetic intermediate thereof, and process for producing them
EP0253785B1 (en) Efficient stereoconservative syntheses of 1-substituted (s)- and (r)-2-aminomethylpyrrolidines and intermediates therein
EP3735402A1 (en) Methods for preparation of jasmonate compounds
CA2387997C (en) Process for preparing oxazolines from tetrahydrofurans
EP3299364B1 (en) Nebivolol synthesis method and intermediate compound thereof
US7078543B2 (en) Methods for producing oxirane carboxylic acids and derivatives thereof
CA3048084A1 (en) Protected oxadiazacyclic compounds, method for preparing oxadiazacyclic compounds and uses thereof
Qu Acylative kinetic resolution of biaryl alcohols using isothiourea catalysis
RU2414464C9 (en) Method of producing n-[3-[(2-methoxyphenyl)sulfanyl]-2-methylpropyl]-3,4-dihydro-2h-1,5- benzoxathiepin-3-amine
JP4123540B2 (en) Process for producing 2-oxo-3-oxabicyclo [3,1,0] hexane

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2006541998

Country of ref document: JP

NENP Non-entry into the national phase in:

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP

122 Ep: pct application non-entry in european phase